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1. ABBREVIATIONS 
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MICU1 mitochondrial calcium uptake 1 
MCUR mitochondrial calcium unicomplex regulator 
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NRVMs neonatal rat ventricular myocytes 
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2. SUMMARY 
Studies on mechanisms underlying cardiac injury caused by ischemia and reperfusion 
(I/R) have provided an enormous contribution to our current understanding of the role 
of mitochondrial dysfunction in cardiac pathophysiology, and it appears clear that 
mitochondria are a central target of I/R injury.  
The rise in Ca2+, which occurs during ischemia and/or at the onset of reperfusion, 
represents a powerful mechanism of injury by acting simultaneously on contractile 
proteins, thus increasing ATP demand and mitochondria, thus potentially reduces ATP 
supply. The deleterious action of Ca2+ is exacerbated by the formation of reactive oxygen 
species (ROS) due to a readmission of oxygen occurring during the post ischemic period. 
Indeed, both Ca2+ and ROS are suggested to play a pivotal role in I/R-induced loss of cell 
viability by promoting the opening of the PTP. In the past the relevance of the 
mitochondrial Ca2+  uniporter in this pathological context has been evaluated using 
Ruthenium derivatives that unfortunately lack selectivity. However, the gap of the 
knowledge regarding the molecular identity of the protein responsible for mitochondrial 
Ca2+ uptake, has been filled by De Stefani and Co.(De Stefani, Raffaello et al. 2011). The 
discovery of the molecular identity of MCU allowed us and others laboratories to 
investigate the role  of MCU in cardiac I/R injury by using genetic approaches. The 
experiments illustrated in this thesis have been carried out by studying the effects of 
MCU overexpression in both isolated cardiomyocytes and intact heart. 
The isolated myocytes were subjected to classical protocol of simulated I/R adding 5mM 
KCN for 60 minutes (i.e., simulated ischemia) followed by KCN washout (reperfusion) for 
60 minutes. Initially we investigated the effects of MCU deletion by means of shRNA 
transfection. Under this condition, we observed an increase of loss of cell viability 
induced by I/R injury in NRVMs devoid of MCU. This finding appears to confirm the 
results obtained in Finkel’s laboratory showing a lack of protection in hearts lacking MCU 
but this conclusion was then argued by more recent report (Kwong, Lu et al. 2015). Since 
this discrepancy is far to be  solved , we focus our attention in the opposite strategy that 
has not been covered yet in cardiac studies. To this aim the effect of MCU 
overexpression was validated by observing an increase in mitochondrial Ca2+ uptake and 
oxygen consumption rate. We observed an increase in the maximal mitochondrial 
capacity probably due to the activation of the dehydrogenases involved in the 
Krebs’cycle and calcium-dependent. Moreover, NRVMs overexpressing MCU subjected 
to I/R injury, showed a decrease in the loss of cell viability that was parallel with the 
reduction in ROS levels in the onset of reperfusion. We hypothesized that MCU induced 
cardioprotection is a preconditioning-like effect involving the activation of protective 
pathways. To validate this hypothesis we investigated the activation of Akt, a pro-
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survival kinase linked to the IPC phenomenon. Indeed, we showed an activation of Akt 
when MCU is overexpressed in NRVMs. This correlates with a slight increase of ROS 
formation under normoxia. Actually, MCU induced Akt activation detected as an 
increase phosphorylation of Ser473 and Tre308 was abrogated by treatment with the 
antioxidant mercaptopropionylglycine. Since Akt is not activated directly by ROS, we 
investigated the upstream processes focusing on the Ser/Thr phosphatase PP2A. Since 
phosphorylation inhibits PP2A activity the likely consequence is the activation and 
phosphorylation of Akt. These results demonstrate that MCU overexpression determines 
an increase of oxidative stress, that  triggers the Akt activation, and it explains a 
reduction of cell death observed in the post ischemic injury.  
The findings obtained in vitro were extended to in vivo system. To this aim we generated 
a mouse model overexpressing MCU in the heart by means of adeno-associated virus 
type 9 at P8 in C57/BLJ6 mice. We did not observe any significant alterations in mice 
development or heart morphology, neither in survival probability of the mice. When we 
performed the I/R protocol in the Langendorff model MCU overexpressing hearts 
showed a  decrease of  the extent of cell death during post-ischemic reperfusion. The 
loss of cell death was associated with a reduction of oxidative stress. Similarly to what 
we have observed in vitro, MCU overexpression induced an activation of Akt and a 
dephosphorylation of PP2A. Therefore, the sequence of events linking MCU 
overexpression with cardioprotection applies to both isolated myocytes and isolated 
heart. These findings appear to be in contrast with the common concept by which I/R 
injury is caused by an increase in mitochondrial Ca2+. We hypothesized that this concept 
is all valid upon condition of severe elevation of  the mitochondrial [Ca2+]. To test this 
hypothesis, MICU1 was co-expressed with MCU to further increase mitochondrial Ca2+ 
accumulation. The co-expression abrogated the protective efficacy afforded by the 
overexpression of MCU only, this was detected as both an occurrence of cell death and 
ROS formation that was not different from wild type cells. In addition, the co-expression 
abolished the effects of MCU overexpression on Akt and PP2A that are likely crucial in 
determining the protective phenotype. Overall, the present data for the first time 
provide evidence of protective efficacy of an increase in mitochondrial calcium uptake 
driving by MCU overexpression. The link between the increase of Ca2+ uptake and 
reduction of cell death appears to involved a sequence of events where by a mild 
increase in ROS formation causes a decrease in protein phosphatase activity that 
eventually stimulates a pro-survival kinase. Nevertheless, the cardioprotective efficacy 
of a slight increase in mitochondrial Ca2+ uptake is lost when mitochondrial Ca2+ 
accumulation is further increase by the co-expression of MCU and MICU1. This supports 
the notion that mitochondrial Ca2+ overload plays a pivotal role in cardiac injury. Further 
studies are necessary to define the threshold between protective and deleterious levels 
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of mitochondrial calcium and ROS as well as clarifying the signaling pathways involved in 
both injury and protection of the ischemic heart. 
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2. SOMMARIO 
Lo studio dei meccanismi coinvolti nel danno da ischemia-riperfusione hanno 
evidenziato il ruolo centrale delle disfunzioni mitocondriali, facendo emergere 
quest’ultimi come target centrale nel danno da ischemia/riperfusione (I/R). L’aumento di 
Ca2+ , che avviene in fase ischemica e nella fase iniziale della riperfusione rappresentano 
un meccanismo d’elezione per l’induzione del danno cellulare andando ad influire sia 
sulle proteine contrattili sia sull’incremento metabolico di ATP. L’azione deleteria del 
Ca2+ viene esacerbata dall’aumento della formazione delle specie reattive dell’ossigeno 
(ROS), dovuto alla re-introduzione dell’ossigeno nella fase di riperfusione. Inoltre, 
entrambi questi fattori, Ca2+ e ROS sono coinvolti nell’apertura del poro della 
permeabilità mitocondriale determinando così un aumento della morte cellulare. Nel 
passato il ruolo dell uptake di Ca2+ mitocondriale è stato studiato valutando l’effetto dei 
derivati del Rutenio, i quali tuttavia mancavano di selettività. Questo avveniva poichè la 
struttura della proteina responsabile dell uptake del Ca2+mitocondriale era ignota. La 
scoperta dell’identità molecolare di tale proteina definita MCU, ha permesso di utilizzare 
un approccio genetico. Gli esperimenti riportati in questa tesi si occupano dello studio 
della sovraespressione di MCU sia nei cardiomiociti neonatali isolati che nel cuore 
intero.  
I cardiomiociti isolati, in cui MCU è stato silenziato tramite transfezione con shRNA, sono 
stati sottoposti ad un protocollo di I/R utilizzando il KCN. Il dato ottenuto mostrava 
un’aumentata mortalità associata ad un aumento di ROS nella fase post ischemica. 
Questi dati erano in accordo con quanto pubblicato da Finkel, tuttavia in seguito alla 
pubblicazione di altri due paper con dati contrastanti al riguardo l’argomento risulta 
ancora molto dibattuto. In questo studio si è deciso di utilizzare una strategia alternativa 
valutando l’effetto della sovraespressione di MCU nel danno indotto da I/R. 
L’overespressione di MCU induceva un aumento dell’uptake di Ca2+ mitocondriale ed un 
aumento del consumo di ossigeno in condizioni di stress (con l’aggiunta di FCCP), 
probabilmente causata dall’accumulo di Ca2+ che attiva le deidrogenasi Ca2+-dipendenti 
coinvolte nel ciclo di Krebs. Inoltre, abbiamo evidenziato una ridotta mortalità cellulare 
in seguito al danno da I/R in parallelo con una riduzione della formazione di ROS nelle 
prime fasi della riperfusione. Per spiegare l’aumentata protezione indotta da  MCU si è 
supposto che esso inducesse l’attivazione di un meccanismo simile al preconditioning. 
Per confermare questa ipotesi abbiamo valutato l’attivazione di Akt, chinasi coinvolta 
nei meccanismi di preconditioning. Akt risultava più attiva quando MCU è sovraespresso, 
e questo correlava con un aumento di ROS in condizioni di basali. L’attivazione di Akt era 
abrogata dal trattamento con mercaptopropilglicina, un antiossidante. Tuttavia Akt non 
viene modulata direttamente dai ROS, perciò abbiamo focalizzato la nostra attenzione 
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su un meccanismo che ne potesse spiegare la maggiore fosforilazione. Focalizzandoci su 
PP2A, una fosfatasi che regola negativamente Akt e la quale risulta essere inattiva 
quando MCU è sovraespresso. Questi risultati dimostrano che la sovraespressione di 
MCU determina un aumento dello stress ossidativo che porta all’attivazione di Akt. 
Questo potrebbe spiegare la riduzione del danno post ischemico evidenziato. 
I dati ottenuti in vitro sono stati poi ripetuti in un modello in vivo, ottenuto tramite 
l’iniezione di un virus adeno-associato di tipo 9 codificante per MCU-flag in topi 
C57/BLJ6, iniettati all’ottavo giorno dopo la nascita. I topi non mostravano alcuna 
alterazione nello sviluppo né nella morfologia cardiaca né nella sopravvivenza. Il cuore 
isolato sovraesprimente MCU sottoposto ad un esperimento di I/R in Langendorff 
mostrava una riduzione del danno cellulare, correlato ad una riduzione dello stress 
ossidativo. Similarmente a quanto osservato in vitro, abbiamo osservato un’attivazione 
di Akt che correlava con una maggiore fosforilazione di PP2A. I dati fin qui presentati 
sembrano apparentemente in contrasto con la nota nozione che il danno indotto da I/R 
è legato ad un aumento del Ca2+ mitocondriale. Per confermare questa nozione abbiamo 
co-espresso MCU e MICU1 per incrementare ulteriormente l’accumulo di Ca2+ 
mitocondriale. La co-espressione determinava una perdita dell’effetto protettivo visto 
nella sola espressione di MCU, causando una maggiore mortalità cellulare in seguito ad 
I/R e un aumento dello stress ossidativo. La mancata protezione correlava con una 
minore fosforilazione di Akt e conseguentemente una maggiore attivazione di PP2A. 
Questi dati, mostrano per la prima volta un fenotipo protettivo apportato da un 
aumento di Ca2+ dato dalla sovraespressione di MCU. La sequenza di eventi che da un 
aumento di calcio porta ad un aumentata cardioprotezione comprende la produzione di 
ROS che determinano l’inattivazione di alcune fosfatasi, che portano alla successiva 
attivazione di chinasi che aumentano la vitalità cellulare. Tuttavia un eccessivo 
incremento di calcio indotto dalla co-espressione di MCU e MICU1 ha un effetto 
deleterio sulla cellula. In ogni caso, altri studi saranno necessari per comprendere e 
definire qual è il livello di demarcazione tra un effetto benefico o meno di Ca2+ e ROS nel 
danno ischemico, e per specificare quale sia l’esatto meccanismo molecolare 
d’attivazione.    
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3. INTRODUCTION 
3.1. The Ischemia/Reperfusion Injury 
Ischemia and post ischemic reperfusion cause a wide array of mitochondria dysfunction. 
The interruption of oxygen and substrate supply during cardiac ischemia induces a block 
of the mitochondrial ATP synthesis. The first consequence of the inhibition of the 
electron transport chain is the loss of energy conservation and oxidative metabolism. 
Impairment of energy metabolism 
The energy is released from the flux of electrons from reducing to oxidizing components 
of the ETC, this energy is transformed into the extrusion of protons from the 
mitochondrial matrix into the intermembrane space. This movement of protons 
generates a protonmotive force that is composed of membrane potential and pH 
gradient. This protonmotive force is necessary to maintain the ions homeostasis and the 
protein import for the mitochondrial bioenergetics. During hypoxia, the inhibition of the 
ETC due to the lack of oxygen, causes the block of ATP synthesis at the level of F1FoATP 
synthase, for that reason mitochondria are not anymore the main source of ATP, 
however they become a powerful system for hydrolyzing glycolytically-produced ATP. 
Impairment of oxidative metabolism 
The main pathway for the reduction of oxidized pyridine and flavin nucleotides is the 
ETC. These coenzymes are critical for the cellular metabolism, they are not abundant in 
the cells, and they could not be replenished by extracellular sources. During hypoxia, 
their oxidation is mostly catalyzed by lactate dehydrogenase. This permits the 
prosecution of ATP synthesis under anoxic condition through anaerobic glycolysis in the 
cytosol.(Allen and Orchard 1987). 
Impairment of calcium homeostatsis 
Membrane potential and proton gradient are the crucial factors for the mitochondrial 
calcium uptake and release  (Bernardi 1999). During ischemia, the inhibition of the ETC 
causes a profound alteration of the Ca2+ homeostasis. In ischemia, due to ETC inhibition 
the proton gradient is abrogated, and the mitochondrial calcium passively follows the 
rise in the cytoplasmic calcium. During the ischemia the sarcolemmal Na+/H+ exchanger 
is activated due to intracellular acidosis. Moreover , due to inhibition of the sarcolemmal 
Na/K ATPase as a consequence of a decreased  of ATP/ADP ratio, cytosolic sodium 
increases, following the rise in cytosolic calcium via Na+/Ca2+ exchanger, that induces 
the rise in the cytoplasmic calcium. In the reperfusion the recovery of the protonmotive 
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force, determines an increase in mitochondrial Ca2+ uptake, that it is a crucial player 
involved in the triggering opening of the PTP. 
Increased of ROS formation 
ROS modulate a wide variety of process, such as the regulation of growth factors 
signalling, the hypoxic response, inflammation and the immune response. In mammalian 
cells ROS are  produced in different cellular compartments such as the plasma 
membrane, cytoplasm, mitochondria and endoplasmic reticulum (ER), lysosomes and 
peroxisomes. However, mitochondria are well known to be major ROS producers. ETC is 
one of the main source of ROS, due to electrons lacking from complex I and III. Also, 
monoamine oxidases (MAO) play a relevant role in ROS generation. These flavoproteins 
located in the OMM catalyze the deamination of amines such as catecholamines, 
producing large amounts of ROS (Cadenas and Davies 2000). MAO are likely to be 
involved in the amplification of ROS in the cardiac I/R injury, accordingly MAO inhibition 
might have a therapeutic value for treating cardiac diseases (Kaludercic, Carpi et al. 
2011). An additional source of ROS producers is p66Shc, that transfers electrons from 
cytochrome c to oxygen (Giorgio, Migliaccio et al. 2005). The cardioprotective efficacy 
associated with p66(Shc) has been shown to be afforded by other antioxidant 
interventions (Carpi, Menabò et al. 2009) . 
3.2. The role of PTP in the I/R injury 
The permeability transition pore (PTP) defines an increased permeability of the inner 
mitochondrial membrane to ions and solutes activated by matrix Ca2+ in the presence of 
specific inducers, such as Pi and thiol oxidants (Bernardi, Krauskopf et al. 2006). The 
phenomenon is caused by a large channel (i.e. PTP) located in the inner mitochondrial 
membrane (IMM). The PTP opening causes an increase of the inner membrane 
permeability to solutes with a molecular weights up to 1500 Daltons. PTP opening is 
favoured by various factors the most important of them are the rise in matrix calcium 
concentration, an increase in ROS levels and a decrease in mitochondrial membrane 
potential. Thus, PTP opening is involved in cell death, caused by many diseases, including 
heart ischemia (Griffiths and Halestrap 1993). The loss of cell viability is induced by 
prolonged PTP opening, causing the collapse of the membrane potential resulting in ATP 
and NAD+ depletion, matrix swelling, and rupture of the outer membrane space. On the 
contrary, very short open times are not deleterious for the cells. These different PTP 
opening states have been described in isolated mitochondria and intact cells (Hüser, 
Rechenmacher et al. 1998, Petronilli, Penzo et al. 2001).  
The molecular identity of this protein has been elucidated recently(Giorgio, von Stockum 
et al. 2013).  
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Accordingly, the  PTP is formed by a dimers of the FoF1 ATP synthase. FoF1 ATP synthase 
(complex V) is the rotary enzyme that synthesizes the vast majority of ATP in respiring 
cells (Giorgio, von Stockum et al. 2013). This complex is formed by the catalytic F1 
portion, the membrane-bound proton-translocating Fo portion, and a lateral stalk linking 
F1 and Fo. CyPD, a well-characterized protein regulator of the PTP, binds the lateral 
stalk, which acts as a stator to counter the tendency of the F1-catalytic domain to rotate 
with the rotor containing the F1 subunits and a ring of Fo subunits  (Rees, Leslie et al. 
2009). This observation allows the identification of the elusive PTP as a dimer of the 
FoF1 ATP synthase. This  finding solves a long-lasting issue in cell biology and readily 
accommodates the pathophysiological effectors of the pore described in the past. 
Indeed, Ca2+, Mg2+, adenine nucleotides, and Pi bind the catalytic core at F1, and the 
membrane potential and matrix pH, which are key PTP modulators (Giorgio, von 
Stockum et al. 2013). 
 
 
 
3.2.1 PTP effectors 
The most important effectors involved in the PTP opening are: 
 Divalent cations: the opening of the PTP is strongly favoured by accumulation of 
Ca2+ in the matrix; at the opposite it is counteracted by Me2+ ions like Mg2+,  Sr2+, 
Mn2+ 
 ΔΨm : at physiological membrane potential the pore is in the closed state, while 
a membrane depolarization favours the opening of the PTP. Many factors are 
able to modify the threshold voltage, in this case PTP opening can be obtained by 
Figure 3.2.1. Schematic representation of F0F1ATP synthase dimers. F1(dark blue), F0(green and light blue), 
and stalk subunits (red) are illustrated based on recent structural.  
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either depolarization, or by changing the threshold potential. On the other hand, 
mitochondrial depolarization may prevent PTP opening reducing the Ca2+ uptake. 
 Inorganic phosphate favours PTP opening  
 Protons: the probability of PTP opening is sharply increased below and above pH 
7.4. The inhibitory effect of H+ is exerted from the matrix side of the inner 
membrane, and is linked to reversible protonation of histidyl residues. 
 Adenine nucleotides: the probability of pore opening is decreased by adenine 
nucleotides, ADP being more potent than ATP. 
 ROS are well characterized factors increasing the opening probability of PTP. The 
link between PTP and ROS is bidirectionals, since PTP opening causes an increase 
in ROS levels.  This link is also called ROS-induced ROS release and it promotes 
the amplification of the oxidative stress inducing cell injured. 
 
 
 
Findings obtained in many laboratories suggest that PTP opening occurs during post 
ischemic-reperfusion. Indeed, during ischemia, intracellular acidosis along with high 
levels of Mg2+ and ADP overrides the PTP promoting conditions established by ΔΨm 
decrease and increase in Ca2+ and Pi levels. On the contrary, upon reperfusion the 
recovery of pH and the burst of ROS, along with a sudden rise in  matrix Ca2+ 
concentration and Pi represent the ideal scenario for PTP opening.  
3.3. Mechanisms of Death: Role of Necrosis, Apoptosis, and Autophagy 
Cell death following ischemia-reperfusion has been reported to have features of 
apoptosis, autophagy, and necrosis. The precise proportion of each form of death may 
depend on the model (adult versus neonatal, cultured cells versus in vivo). These three 
mechanisms are briefly described. 
Apoptosis 
Apoptosis is a physiological process that occurs in multicellular organisms, also called 
programmed cell death. It is a crucial player in the maintenance of tissue homeostasis, 
organogenesis and tissue remodeling during the embryogenesis in the vertebrates (Brill, 
Torchinsky et al. 1999). This process is also essential for the elimination of potentially 
Figure 3.2. PTP effectors involved in PTP opening in I/R injury.  
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dangerous cells, such as autoreactive lymphocytes T, virus infected or cancer cells. The 
aim of apoptosis is to eliminate unnecessary cells from the organism, through a series of 
coordinated and programmed events (Steller 1995). Apoptosis contributes to 
homeostasis which is obtained when the rate of cell proliferation in the tissue is 
balanced by cell death, the loss of this equilibrium determines the development of 
numerous pathologies (Lowe and Lin 2000). However, some diseases are associated with 
higher rates of apoptosis and excessive cell death. For example, increase in apoptosis 
contributes to loss of cardiomyocytes following ischemic injury during myocardial 
infarction. Apoptosis was originally characterized by chromatin condensation and 
fragmentation, cell shrinkage and plasma membrane budding with release of apoptotic 
bodies that are phagocytised. In this way apoptosis limits the inflammatory response. 
Apoptosis has been characterized by the deletion of proapoptotic proteins or increased 
expression of anti-apoptotic proteins have been evaluated. Activation of caspases is 
thought to be a major mechanism of apoptotic cell death, especially in I/R injury. 
(Czerski and Nunez 2004). Inhibition of caspases results in only a modest reduction in 
infarct size, that is less than that observed with overexpression of antiapoptotic 
proteins(Gottlieb 2005). However, a large number of studies have reported that addition 
of caspase inhibitors reduces infarct size, suggesting an important role for caspase 
activation in ischemia-reperfusion injury (Mocanu, Baxter et al. 2000). Caspase 9 has 
been reported to be activated during ischemia, whereas caspase 8 and 9 are activated 
during reperfusion (Stephanou, Brar et al. 2001). Caspases cleave a large number of 
targets that trigger cell death, such as many mitochondrial proteins accelerating the 
occurrence of cell death. Cytoskeleton or plasma membrane constituents are also 
possible targets through which caspase activation, could lead also to rupture of the 
plasma membrane. 
Authphagy 
Autophagy is another form of death which could play a role in ischemia reperfusion 
injury. Autophagy is a physiological mechanism that removes damaged organelles, such 
as mitochondria or endoplasmic reticulum. Autophagy is also initiated by starvation. 
However, prolonged autophagy can cause cell death. The role of autophagy in the I/R 
injury is still matter of debate. Some studies showed that inhibition of autophagy during 
ischemia or anoxia is detrimental, suggesting a beneficial role for stimulation of 
autophagy during ischemia (Dosenko, Nagibin et al. 2006). However, other papers 
demonstrate that a decrease in beclin1 (a protein that stimulates autophagy) reduces 
ischemia-reperfusion mediated autophagy and myocyte death(Takagi, Matsui et al. 
2007). The issue is further complicate by connections between autophagy and other 
forms of cell death. For example, an increase in Ca2+, as occurs during ischemia, has 
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been shown to increase autophagy (Hoyer-Hansen, Bastholm et al. 2007). Activation of 
calpain, a calcium activated protease has been reported to cleave Atg5, a protein 
involved in autophagy; cleaved Atg5 translocates to the mitochondria where it is 
reported to bind Bcl-2 and thereby stimulate apoptosis (Hamacher-Brady, Brady et al. 
2006). Taken together these data suggest that an increase in calcium induce autophagy 
activation and at the same time could transform some autophagy events to apoptosis.  
Necrosis 
Necrosis is an accidental form of cell death, induced by exogenous stimuli that cause an 
irreversible injury. Necrotic cell death is characterized by cell swelling leading to 
irreversible rupture of the plasma membrane with release of cytosolic components. The 
release of cytosolic components triggers an inflammatory response. Necrosis is 
associated with a large variety of conditions or diseases, such prolonged exposure to 
injury, infection, cancer, infarction, poisoning and inflammation. In addition, also genetic 
mutations or damage to cell genome can induce necrosis. This form of cell death 
initiates with cell swelling, chromatin digestion, and disruption of both plasma and 
organelle and membranes. Late necrosis is characterized by extensive DNA hydrolysis, 
vacuolization of the endoplasmic reticulum, organelle breakdown, and cell lysis. Until 
recently, necrosis was described as a gene- and ATP independent process. However, 
recent studies have demonstrated that necrosis can be regulated and the interventions 
can reduce necrotic cell death (Golstein and Kroemer 2007).  
Death following ischemia-reperfusion injury appears to be a mixture of apoptotic, 
autophagy, and necrotic cell death and it can have features of all three mechanisms, and 
all the three forms of cell death can be regulated and inter-related.  
3.4. Role of Calcium  
Ca2+ during ischemia 
Each systole is initiated by Ca2+ entry via the L-type Ca2+ channel resulting in Ca2+ 
induced Ca2+ release from the sarcoplasmic reticulum, and the combined increase in Ca2+ 
leads to contraction. The Ca2+ that enters via L-type Ca channel is removed from the cell 
primarily by Na+-Ca2+ exchange (NCX) with a small contribution from the sarcolemmal 
Ca2+ ATPase (Bers 2002). The Ca2+ released from the sarcoplasmic reticulum is re-
accumulated into the sarcoplasmic reticulum (SR) via SR/ER Ca2+, pumps that are ATP 
dependent. Studies showed that the rise in cytosolic Ca2+ during ischemia is primarily  
due to Ca2+ entry by reverse mode NCX, secondary to the rise in [Na+]i during ischemia 
(Imahashi, Pott et al. 2005). This occurs because of increased generation of protons 
during ischemia, which are extruded from the cell via Na-H exchange (NHE), resulting in 
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an increase in intracellular Na+  (Murphy, Perlman et al. 1991). Na+ has also been shown 
to enter the cell during ischemia on non-inactivating Na+ channels (Murphy, Cross et al. 
1999). This rise in intracellular Na+, coupled with the depolarized plasma membrane 
results in a reversal of NCX to bring Ca2+ into the myocyte. 
 
 
 
Ca2+ during reperfusion 
During reperfusion extracellular pH rapidly returns to physiological values. However, 
initially the intracellular pH is still acidic and this pH gradient facilitates extrusion of H+ 
from the cell in exchange for Na+ on NHE. The increased cytosolic Na+ can be extruded 
by Na-KATPase or NCX in exchange for Ca2+, thereby raising (at least transiently) Ca2+. 
This process could induce the generation of arrhythmias, that are triggered by Ca2+ 
dyshomeostasis and are one of the principal cause of cell death.  
If arrhythmias are not generated, Ca2+ returns quickly to near normal levels in myocytes 
that survive. However, there can be Ca2+, oscillations (Piper, Meuter et al. 2003), which 
can lead to hypercontracture which will contribute to loss of cell viability. In some other 
case Ca2+ remains high during reperfusion; this causes an irreversible injury to myocyte. 
The different behaviour of myocytes depends on ATP levels (which could depend on PTP 
opening), intracellular Na+ levels, and damage to Ca2+ handling proteins such as the 
ryanodine release channel in the SR. The Ca2+ released from the SR can also be taken up 
by the mitochondria leading to opening of the PTP. Indeed, improving SR Ca2+ handling 
Figure 3.4. Calcium transporters in the cell. Calcium channels transport Ca
2+
 into the cytoplasm upon 
changes in membrane potential or ligand binding. Calcium pumps transport Ca
2+
  from the cytoplasm or into 
the endoplasmic reticulum (ER)  and are energy dependent. Sodium calcium exchanger belong  to 
antiporters transporting Ca
2+
 against sodium ions. Two receptors that are localized in the ER release Ca
2+
  
from the ER store. In mitochondria Ca
2+
  transport is realized through the sodium Ca
2+
  exchanger, the 
mitochondrial Ca
2+
  uniporter and the PTP. 
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has been published to rescue the damage caused by ischemic injury (Piper, Abdallah et 
al. 2008). Moreover, adenoviral mediated overexpression of SERCA was shown to reduce 
infarct size and improve function following ischemia (del Monte, Lebeche et al. 2004).  
3.5. Role of the mitochondrial calcium 
Ca2+ uptake into mitochondria occurs via the mitochondrial Ca2+uniporter, which 
depends on membrane potential and pH gradient. During simulated ischemia, most 
studies suggest that there is a small rise in mitochondrial Ca2+ (Griffiths, Ocampo et al. 
1998). Interestingly, Griffiths et al observed that the rise in mitochondrial Ca2+ during 
ischemia was inhibited by clonazepam (an inhibitor of mitochondrial NCX), thus 
suggesting a role for mitochondrial NCX operating in the reverse mode to increase 
mitochondrial matrix Ca2+ .Moreover, Griffiths et al  reported that 0.1µM cyclosporin A 
(CsA), a PTP inhibitor, protected cells subjected to simulated ischemia and reperfusion. 
(Griffiths, Ocampo et al. 2000). These data highlight the crucial role of the mitochondrial 
Ca2+  in the I/R injury. However till now the role of the mitochondrial calcium uniporter 
has been investigated using a pharmacological approach that lack selectivity. The 
discovery of the protein responsible for the mitochondrial Ca2+ uptake (the 
mitochondrial Ca2+ uniporter, MCU), has opened the way to genetic approach to 
elucidate the role of the mitochondrial calcium uniporter in the cardiac injury induced by 
ischemia and reperfusion.  
3.6. Role of ROS 
ROS are derived from molecular oxygen by electron transfer reactions resulting in the 
formation of superoxide anion radical (O2), and subsequently hydrogen peroxide (H2O2), 
either spontaneously, or by the action of superoxide dismutases (SOD). In the presence 
of iron, superoxide and H2O2 can lead to the formation of highly reactive hydroxyl 
radicals which can harm cellular proteins, RNA, DNA and lipids. Interaction of ROS with 
nitric oxide or fatty acids can lead to the formation of peroxynitrite or peroxyl radicals, 
respectively, that are also highly reactive. Superoxide is not freely diffusible, but can 
cross membranes via ion channels. Extracellular superoxide has been shown to enter the 
cell via the anion blocker sensitive chloride channel-3 (Hawkins, Madesh et al. 2007), 
while voltage-dependent anion channels of the mitochondrial outer membrane can 
direct superoxide flux from mitochondria to the cytosol (Han, Antunes et al. 2003). On 
the other hand, hydrogen peroxide can diffuse through membranes and could act as a 
messengers in signaling pathways. Aquaporins can manage the transmembrane 
diffusion of hydrogen peroxide, regulating the levels of hydrogen peroxide in the 
cytoplasm, intracellular organelles, and the extracellular space (Bienert and Chaumont 
2014). There is increasing evidence describing ROS as important signaling molecules 
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controlling cell proliferation, cellular migration, vascular tone, but also cell death. 
(Holmstrom and Finkel 2014). 
ROS in the ischemia and reperfusion injury 
ROS formation occurs at a low, if any, extent during ischemia. Controversially, during 
reperfusion, with the readmission of oxygen, a large burst of ROS has been consistently 
shown to occur (Zweier, Flaherty et al. 1987). The increase in ROS during reperfusion is 
probably due to alterations of electron transport chain components, that result in 
inefficient transfer of electrons, generating superoxide. ROS generated at the onset of 
reperfusion lead to extensive damage to the cellular components that hampers the 
maintenance of cell viability because ROS are the primary activators of the PTP opening 
(Kim, Jin et al. 2006). In addition cell death is contributed by PTP opening induced by 
ROS accumulation. It has already been published that the treatment of in vivo and in 
vitro hearts with antioxidants reduced ROS and stunning (Bolli 1998). However, in 
contrast to the general agreement regarding ROS as a crucial player triggering cell death 
in the I/R injury, there are some studies that find no reduction in infarct size upon 
antioxidants treatment. Indeed, ROS generation has been shown to be part of the 
protective signaling pathway causing the activation of the self-defence cellular 
machinery, and in this case the antioxidant treatment can inhibit cardioprotection 
(Chen, Gabel et al. 1995). 
Mitochondria and ROS production 
Mitochondria are thought to be both a major source of ROS as well as a major target for 
ROS damage. Mitochondrial electron transport is one of the primary sources of ROS in 
the cell. The electron transport chain (ETC) within mitochondria constitutes an 
important source of superoxide (O2·−) formation mainly due to leaking electrons from 
complex I (NADH-CoQ reductase) and complex III (cytochrome c reductase). Complex I 
produces O2·− only within the matrix, while complex III can contribute to O2 −· formation 
also in the intermembrane space. In addition to the ETC, there are other sources of ROS 
in the cell, such as the acetyl-CoA generating enzyme pyruvate dehydrogenase (PDH) 
and the Krebs cycle enzyme α-ketoglutarate dehydrogenase (KGDH). Moreover, recent 
finding suggests that also p66shc and MAO could contribute to ROS formation producing 
H2O2. It has been described that even though only low levels of ROS are generated 
during ischemia, this ROS can trigger the damage of the electron transport chain 
(Lesnefsky, Chen et al. 2004); this damage is then thought to lead to increased ROS 
production because of inefficient transfer of electrons. Inhibition of electron transport at 
complex I during ischemia reduces ROS generation. However, ROS generation has been 
shown to be part of the protective signaling pathway of preconditioning (Chen, Gabel et 
al. 1995), as for example diazoxide, an activator of the mitoKATP channel, has been 
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shown to increase ROS (Forbes, Steenbergen et al. 2001), and addition of antioxidants 
has been shown to block the protection afforded by diazoxide. This suggests that low 
levels of ROS generation are important in signaling of cardioprotection. However, high 
levels of ROS, as occurs in the post ischemic reperfusion, can lead to damage to the 
electron transport chain and activation of the PTP.  
3.7. Calcium and ROS a fateful encounter 
Ca2+ primarily supports ATP synthesis by stimulating enzymes of the Krebs’cycle and 
oxidative phosphorylation in the mitochondria, the resulting increase in oxygen 
consumption could favour respiratory chain electron leakage thus increasing ROS levels 
(Brookes, Yoon et al. 2004). Indeed, metabolic rate influences the mitochondrial ROS 
generation (Sohal and Allen 1985). There is further evidence that the metabolic state of 
the mitochondria determines the effects of Ca2+ on mitochondrial ROS levels. When the 
membrane potential is high (no ATP synthesis), Ca2+ uptake results in decreased ROS 
generation. When the membrane potential is set to a depolarized range (ATP synthesis), 
ROS generation is stimulated, or not influenced by Ca2+, depending on the amount of the 
Ca2+ load (Adam-Vizi and Starkov 2010). When mitochondria are overloaded with Ca2+, 
ROS production might increase independently of the metabolic state of mitochondria (Li, 
Fang et al. 2013). Finally, also the PTP is a voltage and Ca2+ dependent channel , whose 
prolonged opening determines a deleterious effect for the cell viability inducing a burst 
of ROS. There is reciprocal crosstalk between Ca2+and ROS production. Indeed, as well as 
Ca2+ regulates ROS generation, also ROS have been shown to modulate the activity of a 
variety of Ca2+channels, pumps and exchangers, such as several Ca2+ transporters 
localized in the plasma membrane, which are redox sensitive. 
For example, the  voltage dependent Ca2+channels (VDCC) present a cysteine residues in 
the pore, that can be oxidized by ROS, inducing changes in activity, trafficking, 
expression and open-time probability. Also the L-type calcium channel can be regulated 
by ROS in smooth muscle cells, increasing the calcium entry. Finally oxidants modulate 
store-operated Ca2+entry (SOCE). ROS can also regulate some intracellular Ca2+ channels, 
such as ryanodine receptors oxidizing (redox sensing) thiol groups and the 
sacro/endoplasmic reticulm Ca2+ATPase (SERCA), their oxidation compromises pumping-
activity (Gorlach, Bertram et al. 2015). 
It appears clear that Ca2+ and ROS are mutually interconnected. Ca2+ can increase 
production of ROS, and at the same time  ROS can significantly alter Ca2+ influx into the 
cell as well as intracellular homeostasis. 
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3.8. ROS  as regulators of signaling pathways 
The action of ROS in various signaling networks is connected to both physiological and 
pathological role. Various stimuli, such as nutrients like fatty acids, growth factors, 
hormones, coagulation factors, cytokines, and hypoxia were shown to act at least 
partially via regulated ROS generation. 
Preconditioning 
Preconditionig (PC) has been originally described by Murry et al. It consisted of 4 cycles 
of 5 minutes of ischemia and 5 minutes of reperfusion just prior to a sustained period of 
ischemia (Murry, Jennings et al. 1986). This protocol conferred resistance against a 
subsequent lethal episode of myocardial ischemia, reducing infarct size, the generation 
of lactate and the rate of fall in ATP. The reduced rate of ATP hydrolysis during ischemia 
could result from a decrease in anaerobic glycolysis. In this respect it can be proposed 
that glycogen is reduced in IPC protocol . An early hypothesis to account for the reduced 
ATP hydrolysis was that PC might inhibit ATP breakdown by reverse mode of the 
F1FoATPase. A second hypothesis was that IF1 binds F1FoATPase inhibiting its activity 
(Rouslin, Erickson et al. 1986) and other observations demonstrated that glycogen is 
significantly reduced during the PC protocol, so anaerobic glycolysis is limited and less 
lactate can be generated during the sustained period of ischemia in PC hearts 
(Steenbergen, Perlman et al. 1993).  A decrease in glycolisis results a decrease in lactate 
formation and acidosis. Consequently, IPC reduces the activation of the Na-Ca exchanger 
so that intarcellular Na+ has not to be extruded from the Na-Ca exchanger. In this way 
IPC reduces the extent of intracellular Ca2+(Fujio, Nguyen et al. 2000) overload. An 
additional mechanism to reduce ATP hydrolysis is through inhibition of Fo-F1 ATPase. 
Beside this metabolic action a large body of evidence support the notion that IPC efforts 
cardioprotection by activating pro-survival pathways. In this respect relevant role is 
played PI3K-Akt-GSK3β pathway. 
Akt-PI3K-GSK3 β pathway 
Initially Akt was described as a oncogenic protein. Akt is upregulated in many types of 
tumors, contributing to facilitating tumor growth through a reduction in apoptosis. In 
the heart Akt is activated downstream of phosphatidylinositol 3-kinase (PI3K) in 
response to stimulation of receptor tyrosine kinases (Fujio, Nguyen et al. 2000), 
glycoprotein 130, and G-protein coupled receptors. (Tong, Chen et al. 2000). 
PI3K is a lipid and protein kinase, that catalyzes the phosphorylation of the inositol ring 
of phosphoinositides at D3 position. Its activation was associated with cytoprotection, 
and it is involved in β-adrenergic receptor endocytosis. Its action is usually attributed to 
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generation of phosphatidylinositol 3,4,5-trisphosphate (PIP3) which facilitates PDK1 
phosphorylation of substrates, such as Akt, p70S6K, PKC. Downstream of PI3K, Akt 
mediates protection by phosphorylating various targets, such as GSK-3β, endothelial 
nitric oxide synthase (eNOS) , the proapoptotic Bcl2-family member BAD, caspase 9. 
Glycogen synthase kinase 3 was initially described in the process of glycogen synthesis. 
This kinase is involved in the regulation of many other cellular functions. Two isoforms 
exist but the β isoform is the most extensively studied in the cardiac pathophisiology. In 
the heart this kinase is involved in pro-apoptotic pathway and that is a suppressor of 
hypertrophic responses. 
Under basal conditions GSK-3β is active. Akt inhibits GSK-3β activity through 
phosphorylation at Ser9. GSK-3β phosphorylation has been reported to be  involved in 
the PC. One modality of protection appears to depend on its interaction with ANT, 
leading to a decrease in the association of ANT with Cyp-D that has been proposed to  
decrease the opening probability of PTP (Nishihara, Miura et al. 2007). A more recent 
study suggested that GSK-3β inhibition might decrease the mitochondrial membrane 
potential, reducing the driving force for the mitochondrial Ca2+uptake and ROS 
formation in reperfusion. The resulting reduction in mitochondrial Ca2+ accumulation 
and ROS level decreases the loss of cell viability .(Nishihara, Miura et al. 2007).  
3.9. MCU 
Mitochondria are very essential components of intracellular Ca2+signaling and cell 
metabolism. Importantly Ca2+regulates key enzymes of the TCA cycle (Denton and 
McCormack 1990). Thus, by determining the rate of ATP production Ca2+ regulates the 
metabolic adaptations to nutrients. (Rizzuto, De et al. 2012) . 
In particular, Ca2+ in the mitochondrial matrix regulates aerobic metabolism. Indeed, 
there are two dehydrogenases of Krebs’cycle (isocitrate dehydrogenase and α-
ketoglutarate dehydrogenase) are stimulated by Ca2+ as well as pyruvate dehydrogenase 
(Melendez-Hevia, Waddell et al. 1996). By activating these hydrogenases more electrons 
are made available for the electron transport chain. The increase flux of electrons results 
in an increase rate of ATP synthesis that matched the ATP demand detected by 
contractility activated by Ca2+ in the cytosol. The entry of Ca2+ depends on the 
mitochondrial membrane potential and according to Nerst equation and the 
intramitochondrial [Ca2+] could be six orders of magnitude larger than cytosolic [Ca2+]. 
This enormous Ca2+ accumulation is prevented by release pathways, the most important 
in the heart is the mitochondrial Na-Ca exchange. Although the key role of Ca2+ in 
mitochondrial function and aerobic metabolism has been recognized starting from the 
60s (Carafoli, Rossi et al. 1965), the field has been limited by the lack of knowledge of 
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the molecular identity of the mitochondrial calcium uniporter. This issue was solved in 
2011 by two independent laboratories (De Stefani, Raffaello et al. 2011) (Baughman, 
Perocchi et al. 2011). The investigation of the molecular identity of MCU benefited from 
the genome-wide approach based upon the availability of “MitoCarta”. This 
mitochondria geneteque was obtained by performing mass spectrometry analyses on 
both highly purified and crude mitochondrial preparations from 14 different mouse 
tissues. Another helpful information was that the yeast is not devoid the mitochondrial 
calcium uptake. Finally, MCU has no orthologue in the yeast S. cerevisiae, which lacks a 
Ruthenium Red-sensitive mitochondrial Ca2+ uptake system (Carafoli, Balcavage et al. 
1970). The first protein identified was “mitochondrial calcium uptake 1” (MICU1). This 
protein containing an EF domanis, was recognized as a putative regulator of the 
uniporter. The MitoCarta and MICU1 allowed the final identification of the protein 
CCDC109A, which was termed as MCU and fulfils all the requirements to represent the 
mitochondrial calcium uniporter. Indeed,  this protein demonstrated a Ca2+ selectivity in 
the IMM, and its reconstitution in a planar lipid bilayer generated a Ca2+ current. 
Moreover, a single point mutation abolished the sensitivity of MCU to Ruthenium Red 
(Chaudhuri, Sancak et al. 2013). Notably, the overexpression of CCDC109A/MCU almost 
doubled the mitochondrial Ca2+ content in both intact and permeabilized HeLa cells, 
parallel to a significant decrease in the cytosolic Ca2+content due to enhance the 
mitochondrial buffer activity (De Stefani, Raffaello et al. 2011). On the other hand, the 
down-regulation of MCU strongly inhibits mitochondrial Ca2+ uptake while the re-
introduction of the MCU in knock-down cells fully rescues Ca2+ uptake.  
The nuclear MCU gene, located on chromosome 10, encodes a 40-kDa protein that 
looses its cleavable target sequence during mitochondrial import, resulting in a 35-kDa 
mature form.  Although the topology of MCU was initially a matter of debate , it is now 
clear that both its N- and C-terminal domains are located in  the mitochondrial matrix , 
while its 9-aa linker domain faces the intermembrane space (Baughman, Perocchi et al. 
2011). The two transmembrane α-helixes are highly conserved among different species. 
The fact that MCU contains only  two transmembrane domains has suggested  that 
functional uniporter channel could be formed by MCU oligomers. The predicted 
quaternary structure is compatible with a tetramer, in which eight helices line the 
putative pore region, and the clustering of charged residues in proximity of the pore 
generates a negative electrostatic potential that promotes the passage of Ca2+(Raffaello, 
De Stefani et al. 2013). Indeed, that MCU oligomerizes in the mitochondrial inner 
membrane as part of a larger complex, migrating at an apparent molecular weight of 
480 kDa. Beside, strong evidences support that the uniporter complex includes different 
regulatory subunits and components, described below.  
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MCU B 
Based upon genomic analysis a gene closely related to MCU, has been discovered, 
originally reported as CCDC109B and now known as MCUb (Raffaello, De Stefani et al. 
2013). The encoded protein sharing 50% similarity to MCU possesses two coiled-coil 
domains and two transmembrane domains separated by a short loop that slightly differs 
from MCU. MCUb is conserved in most of the vertebrates and in many plants, but it is 
absent in organisms devoid of  MCU. MCU can self-oligomerize or hetero-oligomerize 
with MCUb. A crucial amino acid substitution in the loop region (E256V) removing one 
critical negative charge in MCUb causes an impairment in Ca2+ permeation both in HeLa 
and in planar lipid bilayers. In addition, the concomitant expression of MCU and MCUb 
greatly decreased the open probability in planar lipid bilayer, even when MCUb is 
present in low amount. Therefore, the notion that the insertion of a small fraction of 
MCUb within the oligomer can efficiently inhibit Ca2+ channeling activity. MCUb silencing 
in  HeLa cells has been reported to increase the mitochondrial Ca2+ uptake. Therefore, 
MCUb has been suggested to be the dominant negative component of MCU complex. 
Notably, the MCU/MCUb ratio varies among different tissue and this is likely to explain 
differences in mitochondrial calcium uptake displayed in different cell types.  
Figure 3.8. Schematic representation of MCU complex 
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EMRE 
Although, in a planar lipid bilayer MCU is sufficient per se to form a Ca2+ channel, the 
situation in vivo is likely to be more complex. In particular the activity of MCU in situ, 
seems to be controlled by EMRE. This 10 kDa protein that spans the IMM and it is 
characterized by possesses a highly conserve C-terminus rich in aspartate residues 
(Sancak, Markhard et al. 2013). This protein has been suggested to be  required for Ca2+ 
channeling activity keeping the MICU1/MICU2 dimer attached to the MCU complex. 
However, it has to be pointed out that species, such as plant where MCU and MICU1 are 
highly conserved EMRE or possible homologues are not present. In any case the 
relevance of EMRE is supported by the observations that in mammalian mitochondrial 
EMRE knockdown abrogated completely the mitochondrial Ca2+ uptake even when MCU 
is overexpressed. The interaction between EMRE and MCU could result in a reciprocal 
stabilization. In fact, EMRE stability is impaired in the absence of MCU, while in EMRE 
MCU complex became smaller. Therefore, EMRE could play a crucial for an efficient 
assembly of the MCU complex.  
The MICU  family 
A group of MCU regulators termed as MICU family promotes the closest stay close in 
resting condition as opposed to more active stay at high [Ca2+] concentration. These 
regulators located in the intermembrane space, they have an EF hand domain to 
increase Ca2+ sensitivity (Mallilankaraman, Doonan et al. 2012). The MICU family is 
responsible for the sigmoidal response of MCU to external Ca2+. 
MICU1, the first discovered member of MICU family, is described as a gatekeeper for the 
channel activity. It keeps MCU in the close state when the [Ca2+] is low, yet its absence 
Figure 3.8.2.  MCU and MCUb relative expression in mouse tissue. The different ratio of MCU/MCUb opens 
the possibility that this ratio set the overall mitochondrial Ca2+, carrying different capacity in different 
tissues. 
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decreases the mitochondrial Ca2+uptake (Csordas, Golenar et al. 2013). Additional 
members have been discovered, such as MICU2 and MICU3 (Lam, Martell et al. 2015). 
Also these regulators are located in the intermembrane space, but their specific role is 
far from being elucidated conclusively. The stability of MICU2 is MICU1 dependent, and 
it appears to act as a gatekeeper at low Ca2+. 
Less is known about MICU3 that is predominantly expressed in the CNS (Plovanich, 
Bogorad et al. 2013).  
MCUR1 
The MCU complex includes also MCUR1. This 40kDa protein of the IMM displays one 
predicted transmembrane domain, and one coiled-coil region, with the N-terminal 
facing the intermembrane space and the major part of the protein exposed to the 
matrix. MCUR1 and MICU1 could co-immunoprecipitate with MCU, but MICUR1 does 
not interact directly with MICU1.  
 SLC25A23 
 
SLC25A23 was recently identified as an additional member of MCU complex (Hoffman, 
Chandramoorthy et al. 2014). It appears to participate in mitochondrial Ca2+ uptake 
through interaction with MCU and MICU1. However the characterization of its role 
needs further investigation. 
3.10. The role of MCU in I/R injury 
Since the molecular identity of MCU has remain elusive until recently, the role of 
mitochondrial calcium uptake has been extensively investigated by means of 
pharmacological approaches the interest in this field is related to both the Ca2+ 
dependent control of substrate oxidation and the pathological associations with a wide 
variety of disease, especially cardiac I/R injury.  
The discovery of the molecular identity of MCU is a crucial information to elucidate the 
role of the mitochondrial calcium uptake in myocardial ischemia and develop potential 
inhibitors. However data obtaining deleting MCU has generated a controversial set of 
information.  
Initially, Pan and Colleagues generated a mice model lacking MCU in CD1 mice, that was 
subjected to I/R injury using the Langendorff model. This model revealed that MCU 
knockdown mice displayed the same degree of I/R injury of WT in addition and 
surprisingly MCU deletion abolished the protective efficacy of CsA. Therefore, these 
findings suggest that the occurrence of cardiomyocyte death during post ischemic 
reperfusion does not depend on both mitochondrial Ca2+uptake and PTP opening. 
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However, the alternative mechanism causing the loss of viability was not at all 
elucidated. It is tempting to hypothesized that the extent of Ca2+ in the cytosol due to 
the lack of mitochondrial uptake might stimulate the activity of various of Ca2+ 
dependent enzymes, such as PLA2 , calpain, and CaMK that have been associated with 
the exacerbation of myocardial injury. The surprising results of initial report were argued 
by two more recently reports that attribute the expected protection to MCU deletion in 
the heart . Molkentin and Collogues generated a C57/BL6J mice with adult and 
cardiomyocyte-specific deletion of MCU. Their mitochondria were refractory to acute 
Ca2+ uptake, with impaired ATP production, and inhibited PTP opening upon acute Ca2+ 
challenge (Kwong, Lu et al. 2015). Mice lacking MCU in the adult heart was protected 
from acute ischemia-reperfusion injury. Even if resting/basal mitochondrial Ca2+ levels 
were normal in hearts of MCU-deleted mice, this mice was unable to immediately sprint 
on a treadmill. Thus, these data suggest that MCU is a dedicated regulator for the 
mitochondrial Ca2+ loading underlying a ‘‘fight-or-flight’’ response that acutely matches 
cardiac workload with ATP production. In addition, Anderson and Collogues using a 
dominant negative mouse heart (DN-MCU), demonstrated that hearts had preserved 
ΔΨm and reduced ROS during ischemia reperfusion but were not protected from 
myocardial death as compared to WT  (Rasmussen, Wu et al. 2015). This paper appears 
to support the notion brought by the paper by Pan and all suggesting that chronic 
inhibition of myocardial MCU leads to previously unanticipated compensatory changes 
that prevent the protection against I/R injury that will be expected from MCU deletion. 
Further studies are necessary to clarify how those possible compensatory changes 
promote the loss of viability during post ischemic reperfusion.  
The current debate on the role of MCU is only based upon studies using MCU deletion 
no information have been generated overexpressing MCU in the heart. We followed this 
approach to generate the information describing in this Thesis.  
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4. MATERIALS AND METHODS 
4.1. Cells culture 
4.1.1. Isolation of neonatal rat ventricular myocytes (NRVMs) 
Ventricular myocytes were isolated from 1-3 days old Wistar rats. Hearts were excised 
from rats anaesthetized with diethyl ether, transferred to an ice cold, sterile solution 
(solution A) containing 140mM NaCl, 4.8mM KCl, 1.2mM MgSO4, 4mM NaHCO3, 1.2mM 
NaH2PO4, 12.5mM D-glucose, 10mM HEPES, pH 7.4, and washed twice. Hearts were 
then cut in small fragments. Tissue fragments were dissociated with an enzyme solution 
containing trypsin (Invitrogen) at 4 °C for overnight, under continuous stirring. 
The day after the small fragments were further dissociated by incubating them with an 
enzyme solution containing Collagenase type I (Gibco), at 37°C for 2 minutes 4 times, 
under continuous stirring. Pooled cell suspensions were pelleted by centrifugation (1000 
rpm, 7 min) . To purify them, cells were filtered and resuspended in growth medium 
consisting of MEM (Invitrogen) supplemented with 10% fetal bovine serum (Gibco) and 
antibiotics (100U/ml penicillin and 100ug/ml streptomycin), and are pre-plated for 90 
min. 
After this incubation, only fibroblasts are attached to the flask, while myocytes remain in 
the supernatant. Cells are counted, diluted to appropriate concentration with MEM 
supplemented with 10% FBS, antibiotics, non-essential amino acids (NEAA) , and 0.1mM 
BrdU, necessary to inhibit cell proliferation. Cells are plated in gelatin O.1% coating and 
cultured for 24 hours in 5% CO2 incubator at 37 °C. The day after the cultured media is 
changed with MEM supplemented with  antibiotics, NEAA and 1x ITS. 
4.1.2. Transfection 
Twenty-four hours after plating, the cells were transfected by lipofectamine 
(Lipofectamine 3000, Life Technologies) following manufacturer’s instructions. Briefly, 5 
μg of DNA and 7.5 μL of lipofectamine were added to 100 μL of optiMEM (Gibco) and 
distributed upon each well of a 6-well plate. After 2 hours of incubation, the transfection 
mix was replaced with fresh complete medium.  
The cells were transfected with mitochondrial HyPer; to measure the H2O2 formation; 
or mitochondria GCaMP to evaluate calcium content within mitochondria, or MICU1 to 
reconstitute the uniporter complex in the cells. Transfected cells were analyzed 24/48 
hours after transfection. 
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4.2.  Amplification and purification of plasmid DNA  
4.2.1. Preparation of competent E. coli cells  
DH10B E. coli cells were inoculated in a 10 mL overnight culture of Luria Bertani (LB) 
broth at 37°C. On the following morning, 1 L of LB broth was seeded with the 10 mL 
overnight culture. The culture was incubated at 37°C while shaking at 250 rpm until the 
optical density measured at 600 nm (OD600) reaches 0.3-0.4. From this point forward, 
the remainder of the preparation was done in the cold room. The 1 L culture was split 
into 50 mL sterile tubes and the cells were pelleted by chilled centrifugation at 2500 g 
for 15 min. The supernatant LB broth was discarded and the pellet resuspended by 
gentle swirling with 100 mL of CaCl2 100 mM. The resuspended cells were incubated on 
ice for 30 min and then pelleted by chilled centrifugation at 2500 g for 15 min. The 
resuspension and centrifugation steps were repeated another time. Finally, the cell 
pellet was gently resuspended in 5 mL of CaCl2 100 mM plus 20% glycerol and divided 
into 60 μL aliquots. The aliquots were flash freezed in liquid nitrogen and stored at 
−80°C.  
4.2.2. Transformation of E. coli  
100 ng of plasmid DNA were added to one aliquot of competent DH10B E. coli cells. 
Another aliquot of competent cells was used as negative control. The DNA-cell mixture 
was incubated on ice for 30 min and then heat shocked by keeping it at 42°C in a 
termoblock for 90 sec. The aliquots were immediately returned to ice for 2 min. The cells 
were recovered by adding 900 μL of LB broth and incubating at 37°C while shaking at 
250 rpm for 1 h. The cells were pelleted by centrifugation at 4000 g for 5 min. The two 
pellets was resuspended in a small volume of LB broth and distributed into previously 
prepared LB agar plates containing ampicillin 100 μg/ml. The plates were incubated in a 
stationary 37°C incubator to grow the bacterial colonies.  
4.2.3. Amplification and purification of plasmid DNA from E. coli  
One colony from LB agar plate seeded with transformed DH10B E. coli was collected and 
inoculated in a 250 mL overnight culture of LB broth at 37°C. On the following morning, 
the bacteria culture was centrifugated at 4000 rpm for 10 min and plasmid DNA was 
extracted and purificated following the manufacturer’s instructions of a commercial kit 
(PureLink HiPure Plasmid Maxiprep Kit, Life Technologies). 
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4.3. Fluorescence Microscopy 
4.3.1. Measurement of reactive oxygen species (ROS) production in situ 
ROS formation in intact cell was measured using two different probes: MitoTracker Red 
(MTR, Molecular Probes, ʎ ec=554nm , ʎ em=576nm) and mitochondrial Hyper. The MTR 
is a rosamine derivative that accumulates selectively in the mitochondria due to the 
difference in the mitochondrial membrane potential. The MTR presents a chloromethyl 
moiety that can bind to the thiol groups present at the level of mitochondrial proteins 
and be retained in these organelles. The increase in the fluorescence intensity is due to 
the oxidation of MTR that occurred detected in presence of ROS production. At the 
moment of the experiments, cells were incubated for 25 minutes at 37°C with 25nM 
MTR in HBSS. Following the incubation , cells were washed twice with HBSS.  
 
 
The second probe that has been used is Mitochondrial HyPer (HyPermit, Evrogen, 
ʎec=420-480nm, ʎem=520nm). It is fully genetically encoded fluorescent sensor capable 
of detecting intracellular peroxide (H2O2). It has been developed on the basis of yellow 
fluorescent protein inserted into the regulatory domain of E. coli protein OxyR. Hyper 
demonstrates submicromolar affinity to hydrogen peroxide and it is insensitive to other 
oxidants tested, and it does not cause artifactual ROS generation due to light exposure. 
The oxidation of OxyR determines a shift in protein conformation that causes an 
increase of fluorescence intensity. 
Fig.4.3.1 HL-1 cardiomyocytes loaded with 25nM MTR and visualized by fluorescence microscopy. Images 
were acquired at the beginning of the experiment (panel A) and after hydrogen peroxide administration, to 
appreciate an increase of fluorescence intensity due to ROS formation (panel B). 
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4.3.2. Measurement of mitochondrial calcium oscillation  
To detect the mitochondrial calcium oscillation in vivo, cell were transfected with mito 
GCaMP (ʎ ec=410-480nm, ʎem=520nm), an encoded genetically protein targeted to 
mitochondria. This probe has been developed on the basis of a GFP. 
4.3.3. Determination of oxidative stress by DHE fluorescence staining 
LV tissue was cryosectioned to 10 micron thick slices using a LEICA CM 1580 microtome, 
termostated at -24°C. Sections were attached to slides. ROS production was determined 
measuring variations in fluorescence intensity of the probe dihydroethidium (DHE). Once 
inside the cell, this probe can be oxidized by ROS to the fluorescent compound ethidium 
and irreversibly binds to nuclear DNA, that determines a further increase in fluorescence 
intensity. DHE (sigma) was prepared as 1mM stock solution in DMSO and then diluted to 
a final concentration of 5µM in degassed PBS.  Because of the solution is photosensible, 
all the operations were carried out in the dark. The slides were incubated with DHE 
solution for 30 minutes at 37°C in a humid atmosphere, and the they were washed three 
times with degassed PBS to remove the excess of DHE. Slides were mounted with 
Prolong solution (Invitrogen) and covered with a cover slide. Slides were analysed using 
a fluorescence microscope and 20x air objective at 568nm and 585nm excitation and 
emission wavelengths respectively.  
4.4. Determination of cell viability 
4.4.1. LDH measurement 
The release of lactate dehydrogenase (LDH) from NRVMs was measured to evaluate cell 
death occurring during post ischemic reperfusion . The same method was used to 
determine the amount of LDH released from the hearts exposed to I/R. In this latter 
Fig.4.3. 2. NRVMs transfected with mitochondria-targeted HyPer mito, stained with mitochondria dye 
MTR and their overlap. 
 
HyPer 
mito
 Mitotracker Red merge 
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case, coronary effluent was collected at 1 min intervals during the 30 min of reperfusion. 
At the end of reperfusion hearts were collected and homogenized for assessing the 
residual activity of LDH in the whole tissue. Since all values were normalized to heart 
weight, the amount of LDH released was expressed as % of total (i.e., 
effluent + homogenate) to rule out possible changes due to variations in heart size. LDH 
activity was determined by spectrophotometrically measuring the absorbance of NADH 
at 340nm(reduction of pyruvate to lactate) accordingly to the following reaction. 
 
4.4.2. Tunel assay 
The rate of apoptosis was measured in NRVMs using the terminal 
deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) method. NRVMs 
were seeded onto 12 well plate pretreated with gelatin and grown in MEM 
supplemented with antibiotics, NEAA and 1x ITS . Cells were then incubated in a solution 
of  10µM propidium iodide for 15 minutes at 37°C  and  visualization of all nuclei was 
performed by staining with Hoechst 33258. Cells were washed twice with PBS to remove 
the excess fluorescence background. The number of total and TUNEL-positive nuclei was 
determined in randomly selected fields by using a Zeiss (Oberkochen, Germany) 
Axioplan microscope (×40 magnification) equipped with a digital camera. 
4.5. Oxygen consumption rate measurement 
NRVMs (60000/well) were seeded onto Seahorse 24-well microplates 24 hours prior to 
the analysis on the Seahorse XF24 extracellular flux analyzer (Biosciences) following the 
manufacturer’s instructions. All experiments were performed at 37°C. Oxygen 
consumption rate data consist of mean rates during each measurement cycles consisting 
of a mixing time of 30 sec and a waiting time of 3 min followed by a data acquisition 
period of 3 min. Rates displayed are basal respiration and rates following addition of 1 
μg/ml oligomycin, 1μM FCCP, 1 μM rotenone and 1 μM antimycin A. The FCCP 
concentration was previously determined as that optimal concentration to maximize the 
stimulation of mitochondrial respiration of cells. 
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4.6. Ischemia Reperfusion Injury 
4.6.1. Treatment protocols for I/R injury in mice 
Adult (aged 4 months) C57/BLJ6 WT mice (Charles River, Milan, Italy) were 
anaesthetized with an intraperitoneal injection of Zoletil 100 (30 mg/kg). Hearts were 
perfused with bicarbonate buffer gassed with 95% O2–5% CO2 at 37 °C (pH 7.4) at a 
constant flux of 5 ml/min. Perfusion was performed in the nonrecirculating Langendorff 
model. The perfusion buffer contained (in mM) 118.5 NaCl, 3.1 KCl, 1.18 KH2PO4, 25.0 
NaHCO3, 1.2 MgCl2, 1.4 CaCl2 and 5.6 glucose. Hearts were treated as follows (n ≥ 
3/group): after 10 min of stabilization, hearts were subjected to 40 min of global 
ischemia (I-40) by stopping the coronary flow and 30 min of reperfusion (R-30). After 
reperfusion hearts were quickly immersed into PBS containing 0.5% Triton X100 and 
homogenized for measurement of lactate dehydrogenase (LDH). 
4.6.2. I/R protocol in NRVMs 
Neonatal ventricular cardiac myocytes were incubated with a balanced salt solution. The 
composition was as followed: NaCl 115 mM, KCl 5 mM, KH2PO4 1 mM, MgSO4 1.2 mM; 
CaCl2 2 mM and HEPES 25 mM. Simulated ischemia was induced adding 5mM potassium 
cyanide (KCN) and 20mM 2-deoxy-D-glucose, and maintained for 60 minutes in a 5% 
CO2 at 37°C. simulated reperfusion was induced by removing cyanide and rinsing cells 
twice with PBS, after that cell were kept for additional 60 min in a solution composed of 
NaCl 150 mM, MgSO4 2mM, CaCl2 2mM, HEPES 20mM, Glucose 10mM for 60 minutes 
during the reperfusion period. 
 
 
Figure 4.5.1. The fundamental parameters of mitochondrial function: basal respiration, ATP turnover, 
proton leak, maximal respiration and spare respiratory capacity. 
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4.6.3. Hypoxia/Reperfusion  protocol in NRVMs  
The microfluidic chip used for H/R experiment is composed by three indipendent culture 
chambers and a climatic chamber in an overall surface of 17x15 mm.  The chip is divided 
into three layers: the glass coverslip makes the culture surface, a thin layer of highly gas 
permeable PDMS confines the culture chamber separating the liquid phase from the 
upperlayer in which the gas flows. Fast transitions from normoxic to anoxic conditions 
can be achieved using this chamber. The cells were subjected to 3 hours of hypoxia (95% 
N2 and 5% O2) followed by 3 hrs of reperfusion (95% air and 5% CO2). 
 
4.7. Protein analysis by gel electrophoresis (Western Blot) 
4.7.1. Samples preparation 
Samples were prepared by frozen LV tissue stored at -80°C. 50mg was homogenized in 
1ml lysis buffer. The composition of lysis buffer was: 
50mM Tris 
150mM NaCl 
10mM MgCl2 
1mM EDTA 
2% SDS 
1% Triton 
10% Glicerol 
1X protease inhibitor mix (Roche) 
1X phosphatase inhibitor (Roche) 
Homogenized samples were centrifuged at 13000xg for 10 minutes at 4°C and the pellet 
was discarded. Protein concentration was determined by Bradford assay. To denature 
and solubilize the protein the sample buffer was added , and samples are heated at 70°C 
for 10 minutes at 1250rpm. Then they were loaded in a gel or aliquoted and stored at -
80°C.  
Other samples were obtained from NRVMs. Cells were washed twice with PBS and then 
200µl of RIPA buffer was added in each 6 well plate. Ripa Buffer was composed of: 
25ml PBS 
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1% NP-40 (100%) 
0.25% C₂₄H₃₉NaO₄ 
2mM EDTA 
1X anti protease inhibitor (Roche) 
2X anti phosphatase inhibitor (Roche). 
Cells were scraped and centrifuged at 12000xg for 10 minutes at 4°C. Then the pellet 
was discarded and the protein concentration was determined by Bradford assay. To 
denature and solubilize the protein the sample buffer was added , and samples are 
heated at 70°C for 10 minutes at 1250rpm. Then they were loaded in a gel or aliquoted 
and stored at -80°C. 
4.7.2. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot 
Electrophoresis was performed on polyacrylamide gel prepared in glass slabs 1mm thick 
with 12% acrylamide in the separating gel and 4% in the stacking gel. The following 
solutions were used for the preparation of the gel and the electrophoresis run: 
Acrylamide/bisacrylamide: 30% acrylamide and 0.8% bisacrylamide 
Lower Tris-HCl (4x): 1.5M Tris-HCl and 0.4% SDS, pH 8.8 
Upper Tris-HCl (4x): 0.5M Tris-HCl and 0.4% SDS, pH 6.8 
Running buffer (4x): 0.1M Tris-HCl, 0.77M glycine and 0.4% SDS, pH 8.3 
The polymerization of the gel was obtained by the addition of TEMED (Invitrogen) and 
ammonium persulfate 0.1 mg/ml (invitrogen). Samples were run on the gel at room 
temperature using an Electrophoresis Power Supply (Apelex) that provided a constant 
voltage of 70V in the stacking gel and 120V in the separating gel. In order to make the 
proteins accessible to antibody detection, they were moved from within the gel onto a 
nitrocellulose membrane. 
Once the samples finished the run, the gel was washed from the excess SDS with 
Transfer Buffer (Tris 25mM, glycine 192mM, methanol 20%, pH 8.0). A 0.45μm 
nitrocellulose membrane (BioRad Laboratories) was placed on top of the gel, avoiding 
creating bubbles, and a stack of tissue papers placed on the top. This stack was then 
inserted into a transfer box filled with Transfer Buffer, so that the gel is oriented 
towards the cathode and the membrane towards the anode. When a current is applied 
to the electrodes, this causes the protein migration from the negatively charged cathode 
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to the positively charged anode towards the membrane. The separating  was transferred 
17 h with 150 mA of current. The transfer was performed at 4°C. Once the transfer was 
carried out, the membrane was saturated with BSA 5% in TBS (Tris-HCl 50 mM, NaCl 150 
mM, pH 7.5) for 3h at room temperature. The antibodies used to detect the proteins of 
interest were diluted in BSA 1% in TBS. The following primary antibodies were used: 
Rabbit anti-MCU (Sigma) 
Mouse anti-FLAG (Sigma) 
Rabbit anti-AKT total (Cell Signaling Tecnology) 
Rabbit anti-Thr308 AKT (Cell Signaling Tecnology) 
Rabbit anti-Ser473 AKT (Cell Signaling Tecnology) 
Mouse anti-GADPH (GenTex) 
Rabbit anti-PP2A tot (Cell Signaling Tecnology) 
Rabbit anti-Tyr307 PP2A (Cell Signaling Tecnology) 
Rabbit anti-PP2A-B ((Cell Signaling Tecnology) 
Rabbit anti-PP2A-C (Cell Signaling Tecnology) 
Rabbit anti-GSK3ϐ tot (Santa Cruz Biotecnology) 
Rabbit anti-phospho GSK3ϐ (Santa Cruz Biotecnology) 
All the primary antibody incubations were carried out overnight at 4°C.Following the 
incubation, membranes were washed three times with TBST (TBS and 0.1% Tween 20, 
pH 7.4, 10 minutes each wash). Secondary antibodies were diluted in blocking solution 
and incubated with the membrane for 1 hour at room temperature. Secondary 
antibodies used were: 
Anti mouse (Pierce), dilution 1:2000 
Anti rabbit (Pierce), dilution 1:2000 
Secondary antibody in conjugated to a reporter enzyme, namelyhorseradish peroxidase 
(HRP). When in the presence of a chemiluminescent agent, they can interact and the 
reaction product produces luminescence in proportion to the amount of protein. Prior to 
the detection, membrane was washed three times (15 minutes each wash). 
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4.7.3. Chemiluminescent detection  
Membranes were exposed to LiteAblot PLUS Enhanced Chemiluminescent Substrate 
(EuroClone) for 1 min. This incubation causes the generation of luminous signal due to 
the oxidation of the substrate by horseradish peroxidase bound to the secondary 
antibody. The light, emitted at λmax 340 nm, was detected by a CCD camera (Image 
Station 440 CF, Kodak). 
4.7.4. Densitometry 
Images of the acquired western blots were analysed using the Image J software. This 
program allows the quantification of the optical density of bands or dots that is directly 
proportional to the protein content. 
4.8. In vivo MCU overexpression 
The MCU overexpression was performed using an adeno associated virus type 9, 
injected at P8  in C57/BLJ6 mouse encoding for MCU-FLAG. The efficiency of the 
infection was evaluated performing an immunofluorescence staining using an anti-FLAG 
antibody.    
4.9.  Immunofluorescence  
The efficiency of infection was assessed by staining LV cryosections with anti-FLAG 
antibody to detect the presence of MCU-FLAG encoding by the injected AVV9. Frozen 
crysections of the tissue fixed with paraformaldehyde 1% for 15 min were permeabilized 
with Triton 0.2% in PBS for 10 min. Then they were saturated with BSA 4% in PBS for 1 h. 
All these steps were performed at room temperature. Saturated cryosections were 
incubated with mouse anti-FLAG antibody (GeneTex) 1:100 in BSA 0.5% overnight at 4°C. 
The cells were washed 3 times with PBS for 10 min and then incubated with Alexa Fluor 
647 goat anti-mouse IgG antibody (Life Technologies) 1:100 in BSA 0.5% for 30 min at 
room temperature. The washing steps were repeated. The cryosections were finally 
incubated with 10 μM Hoechst 33342 (Sigma) 10 min at room temperature and the 
coverslips were mounted onto glass slides using ProLong Gold Antifade Reagent (Life 
Technologies). Images were collected using a confocal microscope (Leica SP5), a 63 x oil 
objective and appropriate emission filters. 
4.10.  Statistics  
Results are presented as mean ± standard error. When the experiment was repeated 
more than 3 times, comparisons between two groups of data were performed via 2-
tailed unpaired Student t test. A P-value less than 0.05 was taken to indicate a significant 
difference that was then tagged with an asterisk. 
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5.AIM OF THE STUDY 
Ischemia and post-ischemic reperfusion cause an irreversible alteration of cardiac 
myocytes structure and function eventually resulting in a loss of cell viability. A crucial 
role in determining this alteration has been attributed to mitochondria through a 
sequence of events where by a massive increase in intramitochondrial Ca2+ and reactive 
oxygen species (ROS) promote the opening of the mitochondrial permeability transition 
pore that causes cell death. However, mitochondrial Ca2+ and ROS are involved in 
physiological activity as well, in particular an elevation in mitochondrial Ca2+ is required 
for increasing respiration and ATP synthesis while a moderate increase in ROS is 
necessary to stimulate the activity of survival pathways. The advancement in the 
understanding of the role of mitochondrial Ca2+ uptake in the I/R injury in the heart has 
been limited for many years by the lack of knowledge of the responsible protein for 
mitochondrial Ca2+  uptake. Therefore, the link between the mitochondrial Ca2+  content 
in I/R injury was established by  only pharmacological approaches using non-specific 
drugs. This scenario was radically changed by the discovery of the mitochondrial 
Ca2+uniporter that now allows the use of genetic approaches to define  the role of 
mitochondrial Ca2+ uptake in cardiac pathophisiology.  
The aim of the present thesis was to characterize the role of MCU in cardiac injury 
induced by ischemia and reperfusion. The initial working hypothesis was that the 
deletion of MCU should have a reduce of the loss of cell viability that, on the other hand, 
was expected to increase in experimental models of MCU overexpression. We tested 
this hypothesis both in vitro of isolated cardiomyocytes and in intact heart 
overexpressing MCU by means of infection with AAV9. Surprisingly the result 
contradicted the initial hypothesis especially showing that MCU overexpression confers 
a robust protection against I/R injury. Consequently, we aimed at the elucidating the 
protective mechanism triggers by MCU overexpression. In this case the hypothesis was 
that MCU induced protection mimics the beneficial effect of ischemic preconditioning. 
Accordingly, we hypothesized that the increase in mitochondrial Ca2+ could induce a 
mild oxidative stress promoting the activation of survival kinases and in particular Akt. 
The result obtained both in NRVMs and perfused heart validated entirely our 
hypothesis. Finally, we aimed at demonstrating that the protection afforded by MCU 
overexpression is abolished by a further and massive elevation of mitochondrial calcium. 
This goal was achieved by co-expressing MICU1 with MCU.  
The results obtained in this thesis provide evidence that the transition from protection 
to injury depends on the degree of elevation in mitochondrial Ca2+ and ROS. Indeed, 
while conforming that a massive rise in Ca2+ and ROS hampers the maintenance of cell 
  
47 
 
viability our results demonstrate that a slight increase in mitochondrial content of these 
two factors is a crucial step in eliciting cardioprotection.  
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6.RESULTS 
6.1. Effects of MCU overexpression on NRVMs under normoxic conditions 
By means of adenovirus infection in NRVMs we sought to determine whether an 
increase in the mitochondrial calcium uptake alters mitochondrial morphology and 
function. Initially, WB analysis confirmed that the expression level of MCU in NRVMs was 
increased 9-fold in NRVMs following adenovirus infection (Fig. 6.1.1).  
 
 
An increase in protein expression is not necessarily associated with an increase in 
protein activity. This potential mismatch could be due to an incorrect folding process or 
posttranscriptional processes occurring within a given cell. Therefore, to measure 
whether the overexpressed MCU was function mitochondrial Ca2+ uptake was assessed 
MCU overexpressing NRVMs. Fig. 6.1.2 shows that MCU overxpression increased the 
mitochondrial calcium uptake as comparison to control cells, confirming a previous 
report (Drago, De et al. 2012). 
 
Figure 6.1.1. Expression level of MCU in NRVMs. Infection efficiency was determined by WB analysis. MCU 
overexpression is 9 fold increase in NRVMs after 24 hours virus exposure.  
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Following the demonstration that the adenoviral infection resulted in the 
overexpression of functional MCU, mitochondrial function was monitored by means of 
TMRM fluorescence. Fig. 6.1.3. shows that MCU overexpressing NRVMs did not display 
any significant change with respect to control cells. 
 
 
Due to the relevance of oxidative stress in dysfunction of both mitochondria and 
cardiomyocytes and its link to intracellular [Ca2+] increase, we evaluated ROS formation 
at basal state by using the fluorescent probe MTR which accumulates inside 
mitochondria, as described in the Material and Methods section. As shown in Fig. 6.1.4., 
fluorescence values in MCU overexpressing cells were superimposable to those recorded 
in control NRVMs. 
Figure 6.1.3. MCU overexpression did not affect the mitochondrial membrane potential. NRVMs were 
loaded with TMRM (25 nM) to monitor the mitochondrial membrane potential by fluorescence microscopy 
and the experiment was terminated by adding the uncoupling agent FCCP (4 μM) to fully depolarize 
mitochondria. The graph illustrates the difference in fluorescence intensities obtained before and after FCCP 
that renders the assessment of mitochondrial membrane potential independent of possible variations in the 
cellular (i.e., non-mitochondrial) uptake of TMRM. 
 
 
 
 
 
 
Figure 6.1.2. MCU overexpression enhanced mitochondrial calcium uptake in NRVMs. NRVMs were 
transfected with mtGcAMP, to evaluate the mitochondrial calcium uptake. The first ten frames were 
measured to determine the basal content of calcium in mitochondria. *p<0.05 vs control 
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To further characterize the impact of MCU overexpression on mitochondrial function 
under normoxic conditions, we evaluated oxygen utilization in NRVMs by means of the 
SeaHorse oxygraph. In fact, it has to be pointed out that within the mitochondrial matrix 
Ca2+ activates key enzymes involved in substrate oxidation, such as pyruvate, isocitrate 
and oxoglutarate dehydrogenase. Therefore, by activating these dehydrogenases an 
increase in mitochondrial [Ca2+] increases the feeding electron to the respiratory chain. 
Consequently ATP synthesis is increased to match the increase in ATP demand dictated 
by a rise in cytosolic [Ca2+], as in the case of an increase in force and/or frequency of 
contraction. In situ mitochondrial respiration of plate-attached NRVMs was monitored 
by using an extracellular flux analyzer (i.e., the SeaHorse setup). Five parameters of 
respiration were measured: (1) basal respiration, (2) respiration driving mitochondrial 
H+ leak (after oligomycin addition), (3) maximal respiration (after FCCP addition), (4) 
respiration supported by electron flow through complex II (after rotenone addition), (5) 
non-mitochondrial respiration (after antimycin A addition). MCU overexpressing cells 
showed the same basal respiration as control cells, and we did not detect any significant 
difference also in the respiration parameters (2), (4) and (5). However, when FCCP 
stimulated the maximal respiration by uncoupling the electron transport chain from ATP 
synthesis, mitochondria of MCU overexpressing cells displayed higher rates of oxygen 
consumption. This finding indicates an increase in the activity of the electron transport 
chain as a likely consequence of Ca2+ -induced stimulation of dehydrogenase activities. 
Figure 6.1.4. At basal state MCU overexpression did not affect ROS formation detected by MTR. NRVMs 
were loaded with Mitotracker Red CM-H2XRos (MTR, 25 nM) for 30 minutes at 37°C. 
 
 
 
 
 
 
 
  
51 
 
 
 
6.2. Effect of MCU overexpression on viability of NRVMs subjected to I/R injury. 
Before the elucidation of the MCU molecular identity a general consensus existed that a 
large increase in mitochondrial [Ca2+], such as that occurring upon post-ischemic 
reperfusion, is a determining factor in the loss of viability induced by I/R. In particular, 
the rise in matrix [Ca2+] is likely to promote the opening of the mitochondrial 
permeability transition pore (PTP) that leads to the collapse of the membrane potential, 
cytochrome c release and cell death. In elaborating these notions, the role of 
mitochondrial Ca2+ uptake was defined by means of pharmacological inhibitors devoid of 
specificity. 
The discovery of MCU allowed the genetic testing of the above-mentioned concepts. 
Surprisingly, the initial study on mice lacking MCU showed that the susceptibility to I/R 
injury was not at all affected (Pan, Liu et al. 2013). This conclusion was then argued by 
two papers showing that MCU deletion reduces I/R injury (Kwong, Lu et al. 2015). This 
discrepancy is not solved yet. Before these papers were published, we started 
investigating the effects of changes in MCU expression on the susceptibility to I/R injury 
in NRVMs. To this aim we performed a classical protocol of simulated I/R adding 5mM 
KCN for 60 minutes (i.e., simulated ischemia) followed by KCN washout (reperfusion) for 
60 minutes. The loss of viability was evaluated by assessing the release of LDH in the 
Fig. 6.1.5. MCU overexpressing cells displayed a higher oxygen consumption rate under stress condition. 
To provide a complete characterization of respiratory function, cells were stressed with different stimuli as 
follows: oligomycin to block ATP synthase, FCCP to uncouple the electron transport chain from ATP 
synthesis, rotenone and antimycin A to inhibit complex I and III, respectively. The measured oxygen 
consumption rate was subsequently normalized to the number of viable plated cells. 
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supernatant during the reperfusion period. Fig. 6.2.1 shows that MCU deletion by means 
of siRNA transfection increases the loss of cell viability in comparison to control cells. 
 
 
 
This finding appears to confirm the results obtained in Finkel’s laboratory showing a lack 
of protection in hearts lacking MCU (Pan, Liu et al. 2013). However, due to the ongoing 
controversy and, more importantly the results shown below the rest of the study was 
focused on the effects of MCU overexpression. In fact and surprisingly, as shown in Fig. 
6.2.2 MCU overxpression strongly decreased the cell susceptibility to cell death 
occurring upon post-ischemic reperfusion.  
 
 
Figure 6.2.2. MCU overexpression reduced cell mortality in I/R injury. Cells were subjected to 60 min of 
ischemia (5mM KCN, 20mM DOG), followed by 60 min of reperfusion. Every 15 min the supernatant was 
collected to detect the release of LDH, evaluated using a spectrophotometer analysis. 
Figure 6.2.1. MCU deletion increased the loss of cell viability in I/R injury. MCU deletion was performed 
through shRNA transfection, and to assess the efficiency of the transfection WB was performed using anti-
MCU antibody. After 48 hours of shRNA transfection , a simulated ischemia reperfusion has been 
performed. The release of LDH was evaluated using a spectrophotometer analysis on the supernatant 
collected in the post ischemic period. 
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Then we performed the same experiment using CsA, a desensitizer of the PTP. CsA is 
able to reduce the open probability of the PTP and consequently the occurrence of cell 
death induced by I/R (Di Lisa, Carpi et al. 2011). Confirming its cardioprotective efficacy 
the addition of 1 μM CsA at the onset of ischemia decreased the extent of LDH release. 
Interestingly, not only MCU overexpression afforded a higher degree of protection, but 
also its effect was additive to that of CsA when the two interventions were combined 
(Fig. 6.2.3). 
 
 
To override the limitations of simulated ischemia that is based on the non-physiological 
addition of cyanide, the effects of MCU overexpression were evaluated in a protocol of 
hypoxia-reoxygenation. To this aim we exploited a hypoxia chamber developed in the 
laboratory of Prof. N. Elvassore. This chamber equipped with a microfluidic chip is 
composed by three independent culture chambers and a chamber in an overall surface 
of 17x15 mm. The chip is divided into three layers: the glass coverslip makes the culture 
surface, a thin layer of highly gas permeable PDMS confines the culture chamber 
separating the liquid phase from the upper layer in which the gas flows. This system 
allows the necessary fast transitions from normoxic to anoxic conditions and viceversa 
to implement a reliable in vitro model of hypoxia/reoxygenation mimicking in vivo 
conditions. Preliminary experiments (not shown) were carried out to identify the 
optimal durations of ischemia and reperfusion to obtain the loss of viability in half of the 
plated cells. The optimal protocol was 3 hours of hypoxia (95% N2 and 5%CO2) followed 
by 3 hours of reperfusion (95% air, 5% CO2). The percentage of dead cells was calculated 
as the ratio between propidium iodide positive cells (i.e., dead cells) and the total 
Figure 6.2.3. MCU overexpression reduces cell mortality in I/R injury. Cells were subjected to 60 min of 
ischemia and were incubated with 1μM CsA (5mM KCN, 20mM DOG), followed by 60 min of reperfusion. 
Every 15 min the supernatant was collected to detect the release of LDH, evaluated using a 
spectrophotometer analysis. 
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number of cells stained by diethidium bromide. Confirming the data obtained with 
simulated ischemia, Fig. 6.2.4, shows that in NRVMs overexpressing MCU the extent of 
cell death induced by post-hypoxic reoxygenation was significantly lower than that 
obtained in wild type (wt) cells (41.82% ±8.37 vs 60.44% ±11.68, p<0.05). 
 
 
6.3. Effect of MCU overexpression on ROS levels in NRVMs subjected to I/R injury. 
Upon reperfusion reintroduction of oxygen allows ATP synthesis, yet ischemia-induced 
alterations of the electron transport chain favour the mitochondrial generation of ROS 
providing a relevant contribution to I/R-induced injury. Indeed, the concomitant 
elevation in mitochondrial Ca2+ and ROS stimulates PTP opening that hampers the 
maintenance of cells viability. Counteracting Ca2+ overload and ROS levels represents an 
important strategy to protect the ischemic heart. 
We hypothesized that the cardioprotective effect elicited by MCU overexpression might 
depend on a decreased ROS formation upon reperfusion. To test this hypothesis, 
mitochondrial ROS formation was monitored by means of Mitotracker Red (MTR) 
fluorescence. MTR is a reduced derivative of rosamine whose accumulation in 
mitochondria depends on the mitochondrial membrane potential (Ψm). Of note, the 
reduced probe does not fluoresce until it enters an actively respiring cell, where it is 
oxidized to the corresponding fluorescent mitochondrion-selective probe. Once inside 
mitochondria the chloromethyl moiety drives the covalent binding of MTR to 
mitochondrial proteins, so that the dye remains sequestered in these organelles. 
Therefore, following an increased formation of ROS, especially H2O2, MTR is oxidized 
with a parallel increase in fluorescence, directly proportional to the increase in 
Figure 6.2.4. MCU overexpression reduced cell deth in Hypoxia/Reoxygenation injury. Cells were subjected 
to 3 hours of hypoxia followed by 3 hours of reperfusion. The percentage of viable cells was calculated as 
the ratio between propidium iodide positive cells (i.e., dead cells) and diethidium bromide stained cells (i.e., 
total cell number). 
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mitochondrial oxidative stress. Figure 6.3.1 shows that ROS levels increased in control 
NRVMs upon reperfusion, confirming the well-established occurrence of ROS 
accumulation when oxygenation is re-established after a prolonged period of ischemia. 
Interestingly, MCU overexpression resulted in a significant decrease in ROS 
accumulation validating our hypothesis. 
 
 
MTR fluorescence is affected by several shortcomings the most relevant of which are as 
follows: (i) it is not entirely specific for H2O2; (ii) it is not specific for mitochondria. In 
fact, although in cardiomyocytes mitochondria are the most relevant site for ROS 
formation, MTR can be oxidized becoming fluorescent also outside of mitochondria; (iii) 
its accumulation depends on Ψm. Therefore, low fluorescence value could reflect 
mitochondrial depolarization rather than ROS formation. 
To override MTR limitations, ROS measurements were repeated using the genetically-
encoded probe HyPer (Huang and Sikes 2014) that offers the following major 
advantages: (i) it is ratiometric, so that its fluorescence is independent of intracellular 
levels; (ii) It is highly specific for H2O2. Indeed, its affinity for hydrogen peroxide is in the 
submicromolar range and its fluorescence is not affected by other oxidants tested, such 
as superoxide, oxidized glutathione, nitric oxide, and peroxinitrite; (iii) it does not 
generate ROS upon light exposure as is the case with MTR and many fluorescent small 
molecules (iv) being genetically-encoded it can be used for detection of fast changes of 
H2O2 levels in different cell compartments under various physiological and pathological 
conditions. Thus, HyPer can be targeted to mitochondria to provide a specific 
measurement of H2O2 generated within the mitochondrial matrix. We exploited the 
Figure 6.3.1. Reprfusion-induced ROS formation was decreased in MCU overexpressing cells. NRVMs were 
incubated at 37°C with MTR (25 μM) for 30 minutes. Cells were subjected to 60 minutes of simulated 
ischemia (5mM KCN, 20mM DOG). Upon reperfusion ROS formation was evaluated by monitoring MTR 
fluorescence. 
  
56 
 
mitochondrially targeted HyPer (i.e., HyPer mit) to evaluate mitochondrial ROS 
formation in NRVMs during post-ischemic reperfusion. The results illustrated in Fig. 6.3.2 
confirmed that MCU overexpression resulted in a decreased ROS formation during 
reperfusion.  
 
 
On the other hand, as shown in Fig. 6.3.3, MCU deletion did not modify the increase in 
mitochondrial ROS formation occurring during reperfusion. This finding confirms the 
notion that I/R induced increase in cell mortality correlates with the sudden rise in ROS 
levels that characterizes the reperfusion phase. 
 
 
Figure 6.3.3. MCU deletion affected ROS formation occurred in the post ischemic reperfusion. NRVMs 
deleted MCU through shRNA transfection were subjected to I/R injury. Cells were loaded with MTR for 30 
min at 37°C. The fluorescence intensity was detected to investigate the burst of ROS occurred in the 
reperfusion. 
Figure 6.3.2. ROS formation was decreased in MCU overexpressing cells during reperfusion. NRVMs were 
transfected with mitochondrial HyPer and subjected to the simulated I/R protocol 48 hours later. In 
particular, cells were subjected to 60 minutes of ischemia (5mM KCN, 20mM DOG) and ROS formation was 
evaluated measuring the fluorescence intensity of HyPer during reperfusion. 
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6.4. MCU overexpression determined Akt pathway activation 
Overall, the evidence obtained with both MTR and Hyper suggests that the protection 
elicited by MCU overexpression against I/R-induced cell death is associated with and 
likely depends on a decrease in mitochondrial ROS formation during reperfusion. 
However, it was necessary to clarify the mechanism whereby an increase in 
mitochondrial Ca2+ reduces the extent of ROS formation and cell death during post-
ischemic reperfusion. We focused our attention on Akt activation for the following 
reasons: (i) several cardioprotective strategies are associated with the stimulation of Akt 
activity (Fujio, Nguyen et al. 2000); (ii) in skeletal muscle MCU overexpression 
determines an increase in Akt activation (Mammucari, Gherardi et al. 2015) although the 
link was not elucidated.. 
Akt has been shown to play a critical role in cell growth, transcription regulation and cell 
survival. Akt is activated downstream of phosphatidylinositol 3-kinase (PI3K) in response 
to stimulation of receptor tyrosine kinases and G-protein coupled receptors (GPCRs). In 
1986 a seminal study demonstrated that a powerful cardioprotection can be obtained by 
performing several brief periods of ischemia (usually 3 cycles of 5 min of ischemia 
followed by 5 min of reperfusion) prior to the prolonged lethal ischemic insult (Murry, 
Jennings et al. 1986). This phenomenon was termed ‘ischemic preconditioning’ (IPC). 
Although the mechanisms involved in IPC protection are still matter of debate, several 
reports indicate the crucial role of an increased phosphorylation of Akt causing its 
activation. Akt is thought to mediate protection by phosphorylation of a number of 
target proteins such as GSK-3β, endothelial nitric oxide synthase (eNOS), the 
proapoptotic Bcl-2 family member BAD, and caspase 9. We hypothesized that Akt 
phosphorylation is increased in in MCU overexpressing condition in NRVMs. This 
hypothesis was validated by the WB analysis illustrated in Fig. 6.4.1 showing that AKT 
phosphorylation is significantly increased in NRVMs overexpressing MCU as compared to 
control cells under normoxic conditions (1,94± 0.027 vs 1±0.01 in MCU overexpressing 
NRVM and control cells, respectively; p< 0.05). 
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An important process downstream of AKt stimulation is GSK-3β phosphorylation 
resulting in its inactivation. GSK-3β phosphorylates and inactivates a number of enzymes 
involved in metabolism, such as acetylCoA-carboxylase, ATP citrate lyase, and pyruvate 
dehydrogenase. Moreover, phosphorylation and inactivation of GSK-3β has been 
reported to be antiapoptotic. In several models inactivation of GSK-3β has been 
reported to both reduce the extent of apoptosis and play a pivotal role in 
cardioprotection (Clarke, Khaliulin et al. 2008). To support the evidence of Akt 
activation, we evaluated also GSK-3β phosphorylation. Figure 6.4.2. shows that GSK-3β is 
more phosphorylated when MCU is overexpressed in NRVMs (1,45±0.054 vs 1±0.043 in 
MCU overexpressing NRVM and control cells, respectively; p<0.05). 
 
 
 
 
Figure 6.4.1. MCU overexpression resulted in Akt activation. MCU overexpression induced an higher Akt 
phosphorylation. Western blot with anti-pAkt (Ser473) antibody of lysates from NRVMs cells infected with 
MCU-flag adenovirus. 
 
 
Figure 6.4.2. MCU overexpression increased GSK-3β phoshorylation. MCU overexpression induced a higher 
degree of GSK-3β phosphorylation. Western blot with anti-pGSK3β (Ser9) antibody was carried out in lysates 
from NRVMs infected with MCU-flag adenovirus. 
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6.5. MCU overexpression determined a slight increase in ROS formation 
A large body of evidence demonstrates the deleterious role of reperfusion-induced ROS 
formation in promoting PTP opening and loss of viability. On the other hand, however, 
oxidants can also trigger signalling pathways involved in protective mechanisms, and 
antioxidants abrogate IPC-induced cardioprotection (Halestrap, Clarke et al. 2007). We 
hypothesized that in normoxic NRVMs the slight increase in mitochondrial [Ca2+] induced 
by MCU overexpression might cause a mild rise in ROS that is eventually responsible for 
Akt activation and cardioprotection. To test this hypothesis mitochondrial ROS 
formation was assessed by means of HyPer mit, especially for its higher sensitivity as 
compared to MTR. Using this approach, Figure 6.5.1. shows that cells overexpressing 
MCU displayed a slight increase in ROS formation with respect to control cells (1,37± 
0,064 vs 1 ± 0.067 in MCU overexpressing NRVM and control cells, respectively; p< 0,05). 
 
 
 
Next we assessed the levels of ROS upon antioxidant treatment. As expected, 
mercaptopropylglicine (MPG) abrogated the rise of ROS levels in NRVMs overexpressing 
MCU (Fig. 6.5.2.). 
Figure 6.5.1. MCU overexpression determined a slight increase in ROS formation. Cells overexpressing 
MCU transfected with HyPer mit showed a slight increase in ROS formation in comparison to control cells. 
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6.6. ROS formation is involved in Akt pathway 
MCU overexpression determines a slight increase of ROS that is detectable using a 
ratiometric and very sensitive probe for hydrogen peroxide. In addition, we observed 
that MCU overexpression induces Akt activation that is likely responsible for the 
decreased susceptibility to I/R injury. We hypothesized that Akt activation was the result 
of a redox process triggered by the slight increase of ROS formation in MCU 
overexpressing NRVMs. The results in Fig. 6.6.1. validate this hypothesis showing that 
the addition of MPG prevented the increase in ROS levels induced by MCU 
overexpression. Therefore, Akt activation appears to result from a mild increase in 
mitochondrial ROS levels in response to a slight elevation of mitochondrial [Ca2+] 
induced by MCU overexpression. 
Figure 6.5.2. Antioxidant treatment reduced ROS formation in MCU overexpressing cells. MPG was added 
in the culture media at the concentration of 500μM. Cells were transfected with HyPer mit, and ROS 
formation was evaluated measuring the fluorescence intensity of the probe. 
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6.7. PP2A is involved in Akt activation 
Akt activity is not directly modulated by ROS. We hypothesized that the ROS-dependent 
Akt activation in NRVMs overexpressing MCU depends on redox sensitive kinases or 
phosphatases upstream of Akt. In particular, an inhibition of Ser/Thr phosphatases may 
lead to Akt activation. We focused our attention on PP2A which, along with other 
Ser/Thr phosphatases, dephosphorylates Thr308 and Ser473 in Akt downregulating its 
activity. 
Protein phosphatase 2A comprises a family of serine/threonine phosphatases containing 
a well conserved catalytic subunit, which is highly regulated by means of 
phosphorylation and methylation. PP2A plays a prominent role in the regulation of 
specific signal transduction cascades (Seshacharyulu, Pandey et al. 2013). The core 
enzyme is a dimer (PP2AD), consisting of a 36 kDa catalytic subunit (PP2AC) and the 
regulatory A with a molecular mass of 65kDa. A third regulatory B subunit can be 
associated with this core structure. In vitro, the catalytic subunit of PP2A can be 
phosphorylated by the tyrosine kinases pp60, pp56, as well as by the epidermal growth 
factor and insulin receptors. The phosphorylation occurs on Tyr 307 that is located in the 
conserved C-terminal part of PP2AC and results in the inactivation of the enzyme. In 
vivo, phosphorylation occurs in response to growth stimulation, insulin and TNFα. ROS 
have been shown to inhibit protein phosphatases 2A in a process that is abrogated by 
Figure 6.6.1 Antioxidant treatment reduced Akt phosphorylation in MCU overexpressing cells. NRVMs 
overexpressing MCU through adenovirus infection were treated with MPG 500μM. After 48 hours of 
treatment, Western blot analysis was performed  with anti-pAkt (Ser473) antibody. 
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antioxidant treatment in neurons (Chen, Liu et al. 2009). In addition, PP2AC is inhibited 
by phosphorylation. 
To test whether ROS could abrogate PP2A activity in our model of MCU overexpression, 
firstly we evaluated the protein expression of the PP2AC subunit, that conserved the 
catalytic domain that was not modified by MCU overexpression (Fig. 6.7.1.). 
 
 
Then, we assessed the extent of Tyr307 phosphorylation in PP2AC that inhibits PP2A 
activity. Fig. 6.7.2. shows that in normoxic NRVMs MCU overexpression resulted in an 
increase in PP2AC phosphorylation as compared to control cells (2.84 ±0.26 vs 1±0.021 
in MCU overexpressing NRVM and control cells, respectively). 
 
 
Figure 6.7.2. MCU overexpression affected PP2A activity. Western blot analysis was performed  with anti-
phosphoPP2AC antibody in NRVMs overexpressing MCU in comparison to control cells. 
 
 
Figure 6.7.1. MCU overexpression did not affect PP2AC protein level. Western blot analysis was performed  
with anti-PP2AC antibody in NRVMs overexpressing MCU in comparison to control cells. 
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Overall, these results suggest that MCU induces a preconditioning-like effect resulting 
from a slight increase in mitochondrial ROS levels in response to an increase in 
mitochondrial Ca2+ uptake. These ROS are involved in Akt activation mediated by 
phosphatase inhibition. The increased activity of Akt is likely to provide a relevant 
contribution to the decreased susceptibility to cell death induced by MCU 
overexpression. For instance, the inactivated phosphorylation of PP2A could be 
catalyzed by Src kinase which is known to be  directly activated by ROS (Chiarugi 2008). 
However,  Further studies are needed to (i) elucidate the link between ROS and PP2A 
phosphorylation and (ii) provide a conclusive evidence of the protective role of Akt 
activation assessing the effects of MCU overexpression in NRVMs devoid of Akt. 
6.8. Effect of MCU and MICU1 co-expression in NRVMs 
Our current understanding of the mitochondrial contribution to I/R injury attributes a 
pivotal role to Ca2+ overload and excessive ROS formation. However, the data described 
above provide evidence that a limited increase in mitochondrial Ca2+uptake triggers a 
preconditioning-like protection whereby a mild oxidative stress stimulates pro-survival 
processes, such as Akt activation. However, the present data do not rule out the notion 
that a large rise in mitochondrial [Ca2+] is a deleterious event that compromises cell 
survival. Accordingly, we sought to investigate whether a further increase in 
mitochondrial Ca2+uptake abolishes the protective effects afforded by MCU 
overexpression. To this aim we investigated the effect of MCU and MICU1 co-expression 
in NRVMs. 
MICU1 was the first discovered member of the MICU family (Mallilankaraman, Doonan 
et al. 2012) and is described as a gatekeeper for the channel activity. At low [Ca2+] 
MICU1 keeps MCU close, so that it could be considered as an inhibitor of MCU function. 
However, its deletion decreases mitochondrial Ca2+uptake suggesting an activating role. 
Indeed MCU-MICU1 co-expression has been reported to increase mitochondrial [Ca2+] 
under caffeine stimulation  as compared to the overexpression of only MCU in HeLa 
cells. 
MICU1-MCU co-expression was obtained by means adenovirus infection in NRVMs that 
were subjected to simulated I/R. As previously described, LDH release in the supernatant 
was assessed to evaluate cell death during post-ischemic reperfusion. Cells 
overexpressing MCU-MICU1 showed a significant increase in cell mortality of 40% in 
comparison to overexpression of MCU only. Therefore, MICU1 abolished MCU-induced 
protection (Fig. 6.8.1).  
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6.9.  MCU MICU1 overexpression affects ROS formation in NRVMs 
Since excess ROS production is a major cause of injury in ischemic hearts, oxidative 
stress was analyzed in NRVMs during post-ischemic reperfusion. To this aim NRVMs 
were transfected with HyPer mit and ROS formation was detected evaluating the 
changes in fluorescence intensity. A large increase in ROS formation was detected in 
MICU1-MCU co-expressing cells and was mostly abrogated by overexpression of MCU 
only. 
 
 
 
 
Figure 6.9.1. MCU-MICU1 increased ROS formation during post ischemic reperfusion. NRVMs were 
transfected with HyPer mit and subjected to I/R injury. Change of fluorescence intensity was evaluated to 
monitor the ROS level in the post ischemic reperfusion.   
 
Figure 6.8.1. MCU-MICU1 co-expression abrogated the cardioprotection afforded by MCU overexpression. 
NRVMs overexpressing MCU-MICU1 through adenovirus infection were subjected to I/R injury. Loss of 
viability was evaluated as the percentage of total LDH activity released in the supernatant during 
reperfusion.  
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6.10. MCU-MICU1 mitochondria were more susceptible to oligomycin-induced 
depolarization 
To further investigate if the increase in the mitochondrial calcium uptake due to MCU-
MICU1 co-expression affects the mitochondrial function we evaluated Ψm using TMRM. 
It is worth pointing out that a defective electron transport chain may not lead to a 
detectable decrease in Ψm if this defect is compensated by the reversal of FoF1-ATP 
synthase. By inverting its normal activity FoF1-ATP synthase hydrolyzes ATP while 
pumping proton out of the matrix in order to maintain the proton gradient. Thus, to 
check whether mitochondria were dysfunctional in MCU-MICU1 overexpressing cells 
due to an excessive mitochondrial [Ca2+], Ψm was measured with TMRM after treatment 
with oligomycin, an inhibitor of the ATP synthase. Figure 6.10.1. shows that oligomycin 
addition caused a rapid drop of Ψm only in NRVMs overexpressing MCU-MICU1 revealing 
a latent mitochondrial dysfunction compensated by the inverse operation of FoF1 ATP 
synthase.  
 
 
6.11. MCU-MICU1 co-overexpression and Akt activation 
These data strongly support that the excessive rise in mitochondrial [Ca2+] caused by 
MCU-MICU1 co-overexpression results in mitochondrial dysfunction. In addition, cells 
overexpressing MCU-MICU1 displayed a higher susceptibility to I/R injury as compared 
to MCU overexpression only. To further demonstrate that a rise in mitochondrial [Ca2+] 
abolishes the protection elicited by MCU overexpression we investigated the effect of 
Figure 6.10.1. Mitochondrial dysfunction in MCU-MICU1 cells indicated by the drop in TMRM fluorescence 
upon oligomycin addition. TMRM fluorescence was monitored following the addition of 3 μM oligomycin 
addition. When indicated 4 μM FCCP was added to fully depolarize mitochondria. Mitochondria 
susceptibility to oligomycin-induced membrane depolarization was quantified as the percentage of all 
analyzed cells whose fluorescence had decreased more than 50% before FCCP addition. 
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MCU-MICU1 co-overexpression on Akt activity. As previously shown a slight increase in 
mitochondrial [Ca2+] due to MCU overexpression is associated with a mild increase in 
ROS levels that trigger Akt activation. Conversely, when also MICU1 was overexpressed, 
the increase in Akt phosphorylation was no longer detectable. This finding illustrated in 
Fig. 6.11.1. explains why protection is lost in NRVMs overexpressing MCU and MICU1. 
 
 
Since Akt is negatively regulated by PP2A (as discussed in previous sections), we 
analyzed PP2A phosphorylation in MCU-MICU1 cells to correlate the decrease in Akt 
phosphorylation with PP2A activity. Figure 6.11.2. shows that MCU-MICU1 co-expression 
abolished the increase of Tyr307 phosphorylation in PP2A caused by MCU 
overexpression only. This finding implies that PP2A is no longer inhibited when MICU1 is 
co-expressed with MCU explaining the decrease in Akt phosphorylation/activity. 
 
 
Figure 6.11.2. MCU-MICU1 co-expression abolished the increase in PP2A phosphorylation induced by MCU 
overexpression only. NRVMs were lysed and protein extracts underwent Western Blot analysis. 
Phosphorylated PP2A and total PP2A were detected using specific antibodies. Band intensities were 
quantified by densitometry using the ImageJ software. 
Figure 6.11.1. Akt activation was abrogated in MCU-MICU1 co-expressing cells. NRVMs were homogenized 
and proteins analyzed by Western Blot as described in Materials and Methods. Phosphorylated Akt and total 
Akt were detected using specific antibodies. Band intensities were quantified by densitometry using the 
ImageJ software. 
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6.12. MCU overexpression in mouse heart 
To translate the findings obtained in vitro into a more complex in vivo setting, we 
investigated cardiac injury induced by I/R-in mice overexpressing MCU in the heart. To 
this aim, C57/BL6 mice were injected i.p. with an Adeno-associated virus (AAV9) 
encoding for the MCU-flag at P8 (8 days after birth). This virus presents a CMV promoter 
that is generally used to drive protein expression in mammalian cells. As shown in Fig. 
6.12.1. P8 was found to represent the optimal time for maximizing the degree of heart 
infection. 
 
 
After 4 months from the single injection, we evaluated the efficiency of virus infection 
using IF staining. We obtained an infection efficiency of 65,3% of MCU-flag expression in 
animals injected with the virus as compared to the control animals injected with PBS. 
The MCU overexpression did not affect the survival probability of the animals, as well as 
their morphology and development. 
6.13. MCU overexpression protected hearts from I/R injury 
To translate the effects observed in vitro in isolated cells, hearts were isolated and 
subjected to I/R injury using the classic model of Langendorff perfusion. After their 
isolation, hearts were stabilized by normoxic perfusion for 10 min. Then, global ischemia 
was induced by interrupting the coronary flow for 40 min (I-40). Finally, the coronary 
flow was restored for 30 min (reperfusion, R-30). During this latter period the effluent 
was collected to measure the release of LDH as a marker of cell death. At the end of 
reperfusion hearts were quickly immersed into PBS containing 0.5% Triton X100 and 
homogenized for assessing the residual content of lactate dehydrogenase (LDH). The 
data obtained in hearts infected with the AAV9 encoding for MCU-flag were compared 
with those observed in control hearts (injected with PBS).  Fig. 6.13.1. shows that also in 
Figure 6.12.1. Cardiac infection efficiency at different time points of injection. Heart cryosections were 
incubated with an anti-flag antibody to evaluate the virus efficiency. The injection efficiency  reached 65,3% 
vs ctrl. 
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intact hearts MCU overexpression resulted in a significant decrease of LDH release 
during reperfusion as compared to wt hearts (17,71 ±7.71% vs 30.16 ±10.35% in MCU 
overexpressing and control hearts, respectively; p<0,05). 
 
 
6.14. MCU overexpression reduced ROS formation in intact hearts subjected to I/R 
injury 
Based upon the information collected in vitro, we investigated whether MCU expression 
affects ROS formation also in intact hearts. Oxidative stress was evaluated in heart 
cryosections stained with DHE. This probe, once inside the cell, can be oxidized by ROS 
to the fluorescent compound ethidium and irreversibly binds to nuclear DNA causing a 
further increase in fluorescence intensity. Fig. 6.14.1. shows that ROS levels are 
significantly decreased in MCU overexpressing hearts with respect to control hearts 
(74,12 ±5,68 vs 100 ±6,89 AU in MCU overexpressing and control hearts, respectively; 
p<0.05). 
Figure 6.13.1. MCU overexpression reduced the loss of viability in the intact heart subjected to I/R. Hearts 
were subjected to a perfusion protocol of I/R (40min of no flow global ischemia followed by 30min of 
reperfusion). The effluent was collected to evaluate the release of LDH as a marker of cell death. MCU 
overexpression reduces by 43% the release of LDH occurring during reperfusion. 
  
69 
 
 
 
Since DHE staining evaluates ROS levels, we added the evaluation of oxidative 
alterations of intracellular components. To this aim we analysed the oxidation of 
tropomyosin (Tm). This modification has been shown to occur in isolated rat hearts 
subjected to post-ischemic reperfusion (Canton, Neverova et al. 2004). The oxidative 
alteration of Tm is functionally relevant, since it is linearly related to contractile 
impairments in both cardiac and skeletal muscles (Canton, Menazza et al. 2011). The 
densitometric analysis shown in Fig. 6.14.2. indicates that MCU overexpression 
decreased the extent Tm oxidation induced by post-ischemic reperfusion (1 ±0.5 vs 
0.276 ±0.23 in MCU overexpressing and control hearts, respectively). However, due to 
large variations between samples and the limited number of samples, the data have not 
yet reached the statistical significance. 
 
 
Figure 6.14.1. MCU overexpression reduced ROS formation in hearts subjected to I/R injury. Mice were 
subjected to the I/R protocol described in the text. Left ventricle sections were stained with DHE and 
visualized by fluorescence microscopy. Fluorescence intensity was quantified using ImageJ software. 
*p<0.05 vs sham. 
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6.15. MCU overexpression correlated with Akt activation in intact heart 
To investigate the possible mechanism that determines a reduction of cell mortality in 
hearts overexpressing MCU, we analysed Akt activation in intact hearts as described in 
the previous sections detailing the in vitro experiments. Fig. 6.15.1. shows that MCU 
overexpression caused a 3-fold increase in Akt phosphorylation as compared to the 
control group (3,18 ±0,12 vs 1 ±0,03 in MCU overexpressing and control hearts, 
respectively; p< 0,05).  
 
 
Figure 6.15.1. Akt was activated in MCU overexpressing hearts. Left ventricles were homogenized and 
proteins analyzed by Western Blot as described in Materials and Methods. Akt phosphorylation (Ser 473) 
was detected using specific antibodies. Band intensities were quantified by densitometry using ImageJ 
software.   
 
 
Figure 6.14.2. Tm oxidation was decreased in MCU overexpressing hearts subjected to I/R injury. 
Myofibrillar proteins were extracted from hearts subjected to I/R injury. MCU overexpressing, n=3; sham, 
n=2. As detailed in the Methods section, extracts were denatured in the absence (non-reducing conditions) 
or presence (reducing conditions) of β-mercaptoethanol and then analyzed by anti-Tm immunoblot. 
Densitometry analysis was quantified using ImageJ software. 
  
71 
 
6.16. MCU overexpression determines an increased in PP2A phosphorylation in intact 
hearts. 
The in vitro experiments described above demonstrate that Akt activation is associated 
with an increased phosphorylation of PP2A that causes its inactivation. Accordingly, we 
analyzed the phosphorylation status of PP2A also in vivo. Fig. 6.16.1 shows that MCU 
overexpression increased the degree of PP2A phosphorylation as compared to control 
hearts (1,26 ±0,249 vs 1 ±0,18 in MCU overexpressing and control hearts, respectively). 
 
 
Therefore, also in intact hearts MCU overexpression causes the inactivation of PP2A 
associated with Akt activation that eventually is likely to be responsible for the 
protection against I/R injury observed in MCU overexpressing hearts. 
 
 
 
 
 
 
 
Figure 6.16.1. PP2A activity was decreased in MCU overexpressing hearts.  LV tissue was homogenized and 
proteins analyzed by Western Blot as described in Materials and Methods. PP2A phosphorylation (Tyr 307) 
was detected using specific antibodies. Band intensities were quantified by densitometry using ImageJ 
software.   
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7.CONCLUSIONS 
The results achieved in this study provide novel evidence regarding the role of MCU in 
the cardiac injury induced by ischemia and reperfusion. Although molecular mechanism 
is still under investigation, the prevailing concept is that during reperfusion the rise of 
both Ca2+ and ROS is a causative effector in determining cell death. In fact, Ca2+ and 
ROS synergize promoting the opening of the PTP. The PTP opening induces a sudden 
change in the permeability of the mitochondrial membrane leading to mitochondrial 
membrane depolarization, release of cytochrome c and depletion of ATP. These 
alterations make the survival of the cell unlikely. The deleterious role of an excessive 
mitochondrial Ca2+ uptake has been suggested by using Ruthenium derivates, that lack 
selectivity. The reason for the pharmacological approach was the lack of knowledge of 
the molecular identity of the mitochondrial Ca2+ uniporter. The elucidation of the MCU 
structure has made possible exploiting genetic approaches to evaluate the role of 
mitochondrial Ca2+ uptake in the injury induced by I/R. 
Here we have demonstrated that the deletion of MCU expression did not protect from 
the loss of cell viability in NRVMs subjected to a simulated I/R in accordance with the 
result obtained by Finkel et all. In addition, also the burst of ROS occurring during post-
ischemic reperfusion was not reduced. These results suggest that MCU inhibition, which 
might allow Ca2+ to accumulate in the cytosol, is unlikely to produce a beneficial 
outcome and could trigger the adverse outcome.  To further investigate the role of the 
mitochondrial Ca2+ uptake we evaluated the effect of MCU overexpression in NRVMs. 
Cells overexpressing  MCU were subjected to both  simulated I/R (5mM KCN, 20mM 
DOG)  and hypoxia/reoxygenation showing an increase in cell viability in comparison to 
control cells. The protection effect was associated with a reduction in ROS formation 
occurring during post ischemic reperfusion. This finding was translated into an in vivo 
model overexpressing MCU by means of adeno-associated virus 9 encoded for MCU-flag. 
Hearts isolated from MCU overexpressing mice were subjected to I/R injury using the  
Langendorff model. Hearts overexpressing MCU showed a significant decrease of both 
cell death and oxidative stress. 
Taken together these data suggest that promoting MCU activity provides a robust 
protection against I/R injury. To clarify the mechanistic link between MCU expression 
and cell susceptibility to I/R injury, we hypothesized that the mild increase in Ca2+  
ascribable to MCU overexpression, elicits a preconditioning-like effect. To validate this 
hypothesis ROS levels were measured at the basal state. MCU overexpressing  cells 
showed a slight increase in ROS levels, that might activate survival pathways. Indeed, we 
found that both in NRVMs and intact heart  Akt was more phosphorylated when MCU 
was overexpressed. Moreover, MCU overexpression was associated with the 
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inactivation of PP2A, a phosphatase that negatively regulates Akt. The relevance of ROS 
formation was demonstrated showing that the antioxidant treatment with MPG 
abolished Akt activation. Therefore , the slight increase in mitochondrial Ca2+ induced 
by MCU overexpression caused  a mild oxidative stress, that triggers self-defense cellular 
mechanism. Although we identified Akt activation through PP2A inactivation, other 
signaling pathways could be activated by either mechanism initiated by the increase of 
mitochondrial Ca2+ level, such as an increase in ATP formation, and/or redox processes 
related to mild increase in mitochondrial ROS. For instance, the inactivated 
phosphorylation of PP2A could be catalyzed by Src kinase which is known to be  directly 
activated by ROS (Chiarugi 2008).  Another redox sensitive phosphatase that is upstream 
of Akt is PTEN that is involved in insulin signalling (Schiaffino and Mammucari 2011). 
Future studies will aim at defining the phosphatases inactivated in redox dependent 
manner that might explain the increase in Akt activation. In addition, it is to 
demonstrate that the protection afforded by MCU overexpression is not detectable in 
cardiomyocytes lacking Akt.  
Even if our results demonstrate that a slight increase in mitochondrial Ca2+ uptake 
affords cardioprotection, we also provide evidence that a large elevation in 
mitochondrial Ca2+ hampered the resistance to I/R injury. This latter part of our study 
lends support to the common concept linking an excessive level of mitochondrial Ca2+ 
with cardiomyocyte injury. To obtain this evidence MICU1 was overexpressed together 
with MCU in NRVMs. The consequent further elevation in mitochondrial Ca2+ abrogated 
the protection induced by MCU overexpression alone against the increase in ROS 
formation and cell death caused by I/R injury. The co-expression abolished also the 
effects of MCU overexpression alone on intracellular signaling. In fact, the increase in 
phosphorylation of Akt and PP2A was prevented by MICU1-MCU co-expression. These 
findings are likely to explain the mechanism by which the co-expression of MICU1-MCU 
results in a different outcome as compare to MCU alone . 
Taken together these observations suggest to take in consideration the role of the 
cytosolic Ca2+. The decreased susceptibility shown in MCU overexpression could be due 
to the mitochondrial buffering capacity that avoid the activation of several Ca2+-
dependent enzymes, such as calpain, CaMK and PLA2, that have already been described 
to aggravate cardiac injury. On the other hand, the activation of these enzymes could 
explain the unexpected adverse outcome resulting from MCU deletion. 
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